Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionextracellular matrix structural constituent

PXDN AEBP1 HSPG2 COL7A1 FRAS1 COL11A2 FN1 COMP LAMA2 LAMA5 PAPLN

8.64e-0618822211GO:0005201
GeneOntologyMolecularFunctioncytoskeletal protein binding

STUB1 BCAS3 SPATA31A7 APC2 ACTA1 DAG1 ACTC1 DLC1 FMN1 WIPF2 NOS2 VASP KIF11 SHROOM3 SPATA31A3 SYNM MIB2 SPATA31A5 CRMP1 KIF7 CORO1A SPATA31A1 RAB11FIP5 RP1 MYO15A AJUBA TNS1

9.47e-05109922227GO:0008092
GeneOntologyMolecularFunctionacetyl-CoA carboxylase activity

ACACA ACACB

1.23e-0422222GO:0003989
GeneOntologyMolecularFunctionactin binding

SPATA31A7 DAG1 FMN1 WIPF2 NOS2 VASP SHROOM3 SPATA31A3 MIB2 SPATA31A5 CORO1A SPATA31A1 MYO15A AJUBA TNS1

3.20e-0447922215GO:0003779
GeneOntologyMolecularFunctionvinculin binding

DAG1 DLC1 SYNM

3.57e-04132223GO:0017166
GeneOntologyMolecularFunctionbeta-catenin binding

APC2 CDH23 NOS2 TJP1 DCHS1 CDH9 PROP1

3.93e-041202227GO:0008013
GeneOntologyBiologicalProcessheart development

ACACB SPEG SAV1 DAG1 ACTC1 WNK1 DLC1 MYLK3 NFATC1 GLI2 FGFR1 EEF1AKMT4-ECE2 HSPG2 FAT4 FN1 ADAMTS1 OBSL1 ECE1 KIF7 NCOR2 TENM4 DCHS1 TCF25 LRP2 ENG SOS1

1.46e-0775721926GO:0007507
GeneOntologyBiologicalProcesscell-cell adhesion via plasma-membrane adhesion molecules

CDH23 WNK1 TENM2 CNTN6 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 PTPN23 TENM4 CELSR3 DCHS1 AJUBA CDH9

1.38e-0631321915GO:0098742
GeneOntologyBiologicalProcessaxon guidance

DAG1 TENM2 CNTN6 GLI2 VASP HSPG2 LAMA2 LAMA5 ISL2 ECE1 CELSR3 LRP2 TNR SOS1

2.35e-0628521914GO:0007411
GeneOntologyBiologicalProcessneuron projection guidance

DAG1 TENM2 CNTN6 GLI2 VASP HSPG2 LAMA2 LAMA5 ISL2 ECE1 CELSR3 LRP2 TNR SOS1

2.45e-0628621914GO:0097485
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

CDH23 CNTN6 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 PTPN23 CELSR3 DCHS1 CDH9

5.33e-0618721911GO:0007156
GeneOntologyBiologicalProcesscell morphogenesis

HEXB TANC2 DAG1 CDH23 TENM2 CNTN6 STRIP2 SYNGAP1 KIDINS220 DLC1 GLI2 PKHD1 VASP HSPG2 SHROOM3 ARHGEF28 FN1 CNTNAP1 OBSL1 LAMA2 LAMA5 ISL2 MAP7 ECE1 CORO1A CELSR3 LRP2 TNR CDH9 SOS1

1.02e-05119421930GO:0000902
GeneOntologyBiologicalProcessmesenchyme migration

ACTA1 ACTA2 ACTC1

1.16e-0552193GO:0090131
GeneOntologyBiologicalProcessanimal organ morphogenesis

ACTA1 ACTA2 SAV1 DAG1 ACTC1 CDH23 DLC1 NFATC1 FMN1 GLI2 SCN10A PKHD1 FGFR1 HOXB13 HSPG2 FAT4 FRAS1 COL11A2 COMP ADAMTS1 LAMA2 LAMA5 DUOX2 NCOR2 DCHS1 LRP2 RP1 MYO15A ENG PROP1 SOS1

1.25e-05126921931GO:0009887
GeneOntologyBiologicalProcessextracellular matrix organization

DAG1 VIT PXDN AEBP1 HSPG2 COL7A1 COL11A2 FN1 COMP ADAMTS1 LAMA2 PAPLN ATXN1L ENG TNR

1.32e-0537721915GO:0030198
GeneOntologyBiologicalProcessextracellular structure organization

DAG1 VIT PXDN AEBP1 HSPG2 COL7A1 COL11A2 FN1 COMP ADAMTS1 LAMA2 PAPLN ATXN1L ENG TNR

1.36e-0537821915GO:0043062
GeneOntologyBiologicalProcessexternal encapsulating structure organization

DAG1 VIT PXDN AEBP1 HSPG2 COL7A1 COL11A2 FN1 COMP ADAMTS1 LAMA2 PAPLN ATXN1L ENG TNR

1.40e-0537921915GO:0045229
GeneOntologyBiologicalProcesscell morphogenesis involved in neuron differentiation

TANC2 DAG1 CDH23 TENM2 CNTN6 SYNGAP1 KIDINS220 GLI2 VASP HSPG2 ARHGEF28 FN1 CNTNAP1 OBSL1 LAMA2 LAMA5 ISL2 ECE1 CELSR3 LRP2 TNR SOS1

1.66e-0574821922GO:0048667
GeneOntologyBiologicalProcesstissue morphogenesis

ACTA1 ACTA2 DAG1 ACTC1 LRG1 DLC1 NFATC1 FMN1 GLI2 PKHD1 FGFR1 VASP HOXB13 FAT4 FRAS1 SHROOM3 LAMA5 DCHS1 LRP2 AJUBA ENG SOS1

1.73e-0575021922GO:0048729
GeneOntologyBiologicalProcesscirculatory system development

ACACB BCAS3 SPEG SAV1 DAG1 ACTC1 WNK1 LRG1 DLC1 PXDN MYLK3 NFATC1 GLI2 FGFR1 EEF1AKMT4-ECE2 HSPG2 FAT4 FN1 COMP ADAMTS1 OBSL1 ECE1 KIF7 NCOR2 TENM4 RTL1 TJP1 DCHS1 TCF25 LRP2 ENG PROP1 SOS1

2.41e-05144221933GO:0072359
GeneOntologyBiologicalProcesstube development

BCAS3 SAV1 DAG1 WNK1 LRG1 DLC1 PXDN NFATC1 FMN1 GLI2 PKHD1 FGFR1 MME SLC23A1 VASP HSPG2 FAT4 SHROOM3 FN1 COMP ADAMTS1 LAMA5 POU3F3 ECE1 ATXN1L NCOR2 RTL1 TJP1 DCHS1 LRP2 ENG SOS1

3.42e-05140221932GO:0035295
GeneOntologyBiologicalProcessmorphogenesis of an epithelium

DAG1 LRG1 DLC1 NFATC1 FMN1 GLI2 PKHD1 FGFR1 VASP HOXB13 FAT4 FRAS1 SHROOM3 LAMA5 DCHS1 LRP2 AJUBA ENG SOS1

3.62e-0561921919GO:0002009
GeneOntologyBiologicalProcessaxonogenesis

DAG1 TENM2 CNTN6 SYNGAP1 GLI2 VASP HSPG2 ARHGEF28 FN1 CNTNAP1 LAMA2 LAMA5 ISL2 ECE1 CELSR3 LRP2 TNR SOS1

3.69e-0556621918GO:0007409
GeneOntologyBiologicalProcessmesenchyme morphogenesis

ACTA1 ACTA2 ACTC1 FGFR1 DCHS1 ENG

6.56e-05652196GO:0072132
GeneOntologyBiologicalProcesscell-cell adhesion

CDH23 WNK1 TENM2 LRG1 CNTN6 ITPKB JAK3 FAT2 GLI2 PKHD1 FAT4 COMP PCDHGC5 DOCK8 PCDH11Y PCDHAC1 PTPN23 CORO1A TENM4 CELSR3 TJP1 DCHS1 CARD11 AJUBA TNR CDH9

8.11e-05107721926GO:0098609
GeneOntologyBiologicalProcessmalonyl-CoA biosynthetic process

ACACA ACACB

1.12e-0422192GO:2001295
GeneOntologyBiologicalProcessneuron projection morphogenesis

TANC2 DAG1 TENM2 CNTN6 SYNGAP1 KIDINS220 GLI2 VASP HSPG2 ARHGEF28 FN1 CNTNAP1 OBSL1 LAMA2 LAMA5 ISL2 ECE1 CELSR3 LRP2 TNR SOS1

1.36e-0480221921GO:0048812
GeneOntologyBiologicalProcessheart morphogenesis

SAV1 DAG1 ACTC1 DLC1 NFATC1 FAT4 ADAMTS1 NCOR2 DCHS1 LRP2 ENG SOS1

1.75e-0432121912GO:0003007
GeneOntologyBiologicalProcessneuron development

TANC2 NR2F6 DAG1 CDH23 WNK1 TENM2 CNTN6 SYNGAP1 KIDINS220 GLI2 FGFR1 VASP HSPG2 FAT4 ARHGEF28 FN1 ADAMTS1 CNTNAP1 OBSL1 LAMA2 LAMA5 ISL2 ECE1 CRMP1 TENM4 CELSR3 TMEM132E LRP2 RP1 TNR SOS1

1.78e-04146321931GO:0048666
GeneOntologyBiologicalProcesscentral nervous system development

DAG1 VIT CNTN6 DLC1 GLI2 PRMT5 FGFR1 QARS1 SLC23A1 NPAS1 EEF1AKMT4-ECE2 HSPG2 FAT4 ARHGEF28 CNTNAP1 DUOX2 ISL2 POU3F3 ATXN1L NCOR2 TENM4 LRP2 KDM4A TNR PROP1 SMAD9 SOS1

1.80e-04119721927GO:0007417
GeneOntologyBiologicalProcessplasma membrane bounded cell projection morphogenesis

TANC2 DAG1 TENM2 CNTN6 SYNGAP1 KIDINS220 GLI2 VASP HSPG2 ARHGEF28 FN1 CNTNAP1 OBSL1 LAMA2 LAMA5 ISL2 ECE1 CELSR3 LRP2 TNR SOS1

1.81e-0481921921GO:0120039
GeneOntologyBiologicalProcessaxon development

DAG1 TENM2 CNTN6 SYNGAP1 GLI2 VASP HSPG2 ARHGEF28 FN1 CNTNAP1 LAMA2 LAMA5 ISL2 ECE1 CELSR3 LRP2 TNR SOS1

1.81e-0464221918GO:0061564
GeneOntologyBiologicalProcesscell projection morphogenesis

TANC2 DAG1 TENM2 CNTN6 SYNGAP1 KIDINS220 GLI2 VASP HSPG2 ARHGEF28 FN1 CNTNAP1 OBSL1 LAMA2 LAMA5 ISL2 ECE1 CELSR3 LRP2 TNR SOS1

2.03e-0482621921GO:0048858
GeneOntologyBiologicalProcessmorphogenesis of a branching epithelium

DAG1 NFATC1 GLI2 PKHD1 FGFR1 HOXB13 FAT4 LAMA5 DCHS1 ENG

2.25e-0423621910GO:0061138
GeneOntologyBiologicalProcessembryonic morphogenesis

DAG1 CDH23 WNK1 DLC1 GLI2 FGFR1 VASP HSPG2 FRAS1 SHROOM3 FN1 LAMA5 PAF1 ECE1 TENM4 LRP2 MYO15A ENG SOS1

2.29e-0471321919GO:0048598
GeneOntologyBiologicalProcesspeptide metabolic process

AEBP1 MME TAPBP SPPL3 CPZ ECE1

2.73e-04842196GO:0006518
GeneOntologyBiologicalProcesssubstance P catabolic process

MME ECE1

3.34e-0432192GO:0010814
GeneOntologyBiologicalProcesshypophysis morphogenesis

DUOX2 PROP1

3.34e-0432192GO:0048850
GeneOntologyBiologicalProcesstube morphogenesis

BCAS3 DAG1 WNK1 LRG1 DLC1 PXDN NFATC1 FMN1 GLI2 PKHD1 FGFR1 VASP HSPG2 FAT4 SHROOM3 FN1 COMP ADAMTS1 LAMA5 RTL1 TJP1 DCHS1 LRP2 ENG SOS1

3.94e-04112521925GO:0035239
GeneOntologyBiologicalProcessepithelium development

SAV1 DAG1 CDH23 LRG1 DLC1 NFATC1 FMN1 GLI2 PKHD1 FGFR1 HSF4 VASP HOXB13 FAT4 FRAS1 SHROOM3 LAMA5 POU3F3 MAP7 ECE1 NCOR2 TCHH TJP1 TMEM132E DCHS1 LRP2 CEP152 AJUBA ENG SOS1

4.26e-04146921930GO:0060429
GeneOntologyBiologicalProcessmorphogenesis of a branching structure

DAG1 NFATC1 GLI2 PKHD1 FGFR1 HOXB13 FAT4 LAMA5 DCHS1 ENG

4.56e-0425821910GO:0001763
GeneOntologyCellularComponentbasement membrane

ACTA2 DAG1 PXDN HSPG2 COL7A1 FRAS1 FN1 ADAMTS1 LAMA2 LAMA5 PAPLN

7.91e-0812222311GO:0005604
GeneOntologyCellularComponentcollagen-containing extracellular matrix

ACTA2 DAG1 VIT PXDN AEBP1 AHSG HSPG2 COL7A1 FRAS1 COL11A2 FN1 COMP ADAMTS1 LAMA2 LAMA5 PAPLN TNR ZG16

1.66e-0553022318GO:0062023
GeneOntologyCellularComponentextracellular matrix

ACTA2 DAG1 VIT PXDN AEBP1 AHSG HSPG2 COL7A1 FRAS1 COL11A2 FN1 COMP ADAMTS1 LAMA2 LAMA5 PAPLN CPZ TNR ZG16

8.39e-0565622319GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

ACTA2 DAG1 VIT PXDN AEBP1 AHSG HSPG2 COL7A1 FRAS1 COL11A2 FN1 COMP ADAMTS1 LAMA2 LAMA5 PAPLN CPZ TNR ZG16

8.73e-0565822319GO:0030312
GeneOntologyCellularComponentactin cytoskeleton

ACACA APC2 ACTA1 ACTA2 ACTC1 DLC1 MYLK3 FMN1 VASP SHROOM3 CDC42BPB CRMP1 CORO1A TJP1 DCTN6 EFR3B MYO15A

1.60e-0457622317GO:0015629
GeneOntologyCellularComponentlamellipodium

APC2 ACTA1 ACTA2 DAG1 ACTC1 VASP DOCK8 CDC42BPB CORO1A AJUBA

1.90e-0423022310GO:0030027
GeneOntologyCellularComponentextracellular matrix of synaptic cleft

LAMA5 TNR

3.37e-0432232GO:0098965
GeneOntologyCellularComponentcatenin complex

APC2 CDH23 DCHS1 CDH9

3.59e-04322234GO:0016342
GeneOntologyCellularComponentextrinsic component of plasma membrane

APC2 CDH23 TENM2 JAK3 NPTX2 DCHS1 CDH9

6.81e-041372237GO:0019897
GeneOntologyCellularComponentanchoring junction

DAG1 ACTC1 TENM2 FAT2 DLC1 FMN1 MME VASP HSPG2 SHROOM3 SYNM SGCA CNTNAP1 OBSL1 DUOX2 CDC42BPB CORO1A TJP1 AJUBA ENG TNS1 CDH9

7.91e-0497622322GO:0070161
GeneOntologyCellularComponentactin-based cell projection

ACTA1 ACTA2 DAG1 ACTC1 CDH23 TENM2 VASP CORO1A MYO15A CEACAM20

8.42e-0427822310GO:0098858
GeneOntologyCellularComponentcell leading edge

BCAS3 APC2 ACTA1 ACTA2 DAG1 ACTC1 DLC1 VASP DOCK8 DUOX2 CDC42BPB SHISA7 CORO1A AJUBA

1.01e-0350022314GO:0031252
HumanPhenoAplasia/Hypoplasia involving bones of the thorax

KMT2A FGFR1 CHD6 HSPG2 FAT4 FRAS1 COL11A2 OBSL1 LAMA5 CDC42BPB RTL1 DCHS1 LRP2 CEP152

3.94e-061948714HP:0006711
MousePhenoabnormal extracellular matrix morphology

PXDN MYLK3 HSPG2 FRAS1 FN1 LAMA2 LAMA5 RTL1 SOS1

5.54e-061001809MP:0013258
DomainLaminin_G_2

FAT2 HSPG2 FAT4 COL11A2 CNTNAP1 LAMA2 LAMA5 CELSR3

1.69e-08402188PF02210
DomainLamG

FAT2 HSPG2 FAT4 COL11A2 CNTNAP1 LAMA2 LAMA5 CELSR3

3.74e-08442188SM00282
DomainCadherin-like

DAG1 CDH23 FAT2 FAT4 PCDHGC5 SGCA PCDH11Y PCDHAC1 CELSR3 DCHS1 CDH9

1.14e-0711621811IPR015919
Domain-

FAT2 HSPG2 FAT4 NPTX2 COL11A2 COMP CNTNAP1 LAMA2 LAMA5 CELSR3

1.63e-0795218102.60.120.200
DomainLAM_G_DOMAIN

FAT2 HSPG2 FAT4 CNTNAP1 LAMA2 LAMA5 CELSR3

2.49e-07382187PS50025
DomainLaminin_G

FAT2 HSPG2 FAT4 COL11A2 CNTNAP1 LAMA2 LAMA5 CELSR3

3.52e-07582188IPR001791
DomainCarboxyPept-like_regulatory

TENM2 CILP2 AEBP1 CPZ TENM4

1.14e-06172185IPR008969
DomainEGF

TENM2 FAT2 HSPG2 FAT4 FRAS1 COMP CNTNAP1 LAMA2 LAMA5 TENM4 CELSR3 LRP2 TNR

4.09e-0623521813SM00181
DomainCadherin_CS

CDH23 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 CELSR3 DCHS1 CDH9

5.29e-061092189IPR020894
DomainCADHERIN_1

CDH23 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 CELSR3 DCHS1 CDH9

7.12e-061132189PS00232
DomainCadherin

CDH23 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 CELSR3 DCHS1 CDH9

7.12e-061132189PF00028
DomainCADHERIN_2

CDH23 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 CELSR3 DCHS1 CDH9

7.65e-061142189PS50268
Domain-

CDH23 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 CELSR3 DCHS1 CDH9

7.65e-0611421892.60.40.60
DomainEGF-like_dom

TENM2 FAT2 HSPG2 FAT4 FRAS1 COMP CNTNAP1 LAMA2 LAMA5 TENM4 CELSR3 LRP2 TNR

7.67e-0624921813IPR000742
DomainCA

CDH23 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 CELSR3 DCHS1 CDH9

8.22e-061152189SM00112
DomainEGF_1

TENM2 FAT2 HSPG2 FAT4 FN1 COMP CNTNAP1 LAMA2 LAMA5 TENM4 CELSR3 LRP2 TNR

9.90e-0625521813PS00022
DomainCadherin

CDH23 FAT2 FAT4 PCDHGC5 PCDH11Y PCDHAC1 CELSR3 DCHS1 CDH9

1.01e-051182189IPR002126
Domain-

SIGLEC8 SPEG DAG1 CNTN6 HAVCR1 CILP2 FNDC7 PXDN NFATC1 PKHD1 FGFR1 KIR3DL2 TAPBP HSPG2 COL7A1 FN1 SGCA OBSL1 PAPLN FCRL5 TNR CEACAM20

1.09e-05663218222.60.40.10
DomainEGF-like_CS

TENM2 FAT2 HSPG2 FAT4 FN1 COMP CNTNAP1 LAMA2 LAMA5 TENM4 CELSR3 LRP2 TNR

1.27e-0526121813IPR013032
DomainIg-like_fold

SIGLEC8 SPEG DAG1 CNTN6 HAVCR1 CILP2 FNDC7 PXDN NFATC1 PKHD1 FGFR1 KIR3DL2 TAPBP HSPG2 COL7A1 FN1 SGCA OBSL1 PAPLN FCRL5 TNR CEACAM20

2.87e-0570621822IPR013783
DomainConA-like_dom

FAT2 HSPG2 FAT4 NPTX2 COL11A2 COMP CNTNAP1 LAMA2 LAMA5 HNRNPUL1 CELSR3

5.51e-0521921811IPR013320
DomainEGF_2

TENM2 FAT2 HSPG2 FAT4 COMP CNTNAP1 LAMA2 LAMA5 TENM4 CELSR3 LRP2 TNR

6.92e-0526521812PS01186
DomainIg_I-set

SIGLEC8 SPEG CNTN6 CILP2 PXDN FGFR1 HSPG2 OBSL1 PAPLN CEACAM20

8.17e-0519021810IPR013098
DomainI-set

SIGLEC8 SPEG CNTN6 CILP2 PXDN FGFR1 HSPG2 OBSL1 PAPLN CEACAM20

8.17e-0519021810PF07679
DomainACTINS_1

ACTA1 ACTA2 ACTC1

8.41e-0582183PS00406
DomainLAMININ_IVA

HSPG2 LAMA2 LAMA5

8.41e-0582183PS51115
DomainLaminin_B

HSPG2 LAMA2 LAMA5

8.41e-0582183PF00052
DomainLamB

HSPG2 LAMA2 LAMA5

8.41e-0582183SM00281
DomainLaminin_IV

HSPG2 LAMA2 LAMA5

8.41e-0582183IPR000034
DomainIGc2

SIGLEC8 SPEG CNTN6 CILP2 PXDN FGFR1 HSPG2 OBSL1 PAPLN FCRL5 CEACAM20

1.04e-0423521811SM00408
DomainIg_sub2

SIGLEC8 SPEG CNTN6 CILP2 PXDN FGFR1 HSPG2 OBSL1 PAPLN FCRL5 CEACAM20

1.04e-0423521811IPR003598
DomainACC_central

ACACA ACACB

1.36e-0422182PF08326
DomainAcCoA_COase_cen

ACACA ACACB

1.36e-0422182IPR013537
DomainDUF4599

SPATA31A7 SPATA31A3 SPATA31A5

3.19e-04122183PF15371
DomainDUF4599

SPATA31A7 SPATA31A3 SPATA31A5

3.19e-04122183IPR027970
DomainEGF_LAM_2

HSPG2 LAMA2 LAMA5 CELSR3

3.90e-04302184PS50027
DomainEGF_LAM_1

HSPG2 LAMA2 LAMA5 CELSR3

3.90e-04302184PS01248
DomainRhs_assc_core

TENM2 TENM4

4.04e-0432182IPR022385
DomainCADG

DAG1 SGCA

4.04e-0432182SM00736
DomainVPS13

VPS13C VPS13D

4.04e-0432182IPR026847
DomainVPS13_mid_rpt

VPS13C VPS13D

4.04e-0432182PF16910
DomainVPS13

VPS13C VPS13D

4.04e-0432182PF16908
DomainVPS13_N2

VPS13C VPS13D

4.04e-0432182IPR031646
DomainVPS13_mid_rpt

VPS13C VPS13D

4.04e-0432182IPR031642
DomainCadg

DAG1 SGCA

4.04e-0432182IPR006644
DomainCarboxyPept_regulatory_dom

CILP2 AEBP1 CPZ

4.11e-04132183IPR014766
Domain-

CILP2 AEBP1 CPZ

4.11e-041321832.60.40.1120
DomainEGF_3

TENM2 FAT2 HSPG2 FAT4 COMP CNTNAP1 TENM4 CELSR3 LRP2 TNR

4.56e-0423521810PS50026
DomainEGF_CA

TENM2 FAT2 HSPG2 FAT4 COMP CELSR3 LRP2

5.77e-041222187SM00179
DomainEGF-like_Ca-bd_dom

TENM2 FAT2 HSPG2 FAT4 COMP CELSR3 LRP2

6.36e-041242187IPR001881
DomainEGF_Lam

HSPG2 LAMA2 LAMA5 CELSR3

7.12e-04352184SM00180
DomainLaminin_EGF

HSPG2 LAMA2 LAMA5 CELSR3

7.12e-04352184PF00053
DomainActin_CS

ACTA1 ACTA2 ACTC1

7.85e-04162183IPR004001
DomainTox-GHH_dom

TENM2 TENM4

8.01e-0442182IPR028916
DomainSHR-BD

VPS13C VPS13D

8.01e-0442182IPR009543
DomainCarboxyl_trans

ACACA ACACB

8.01e-0442182PF01039
DomainTox-GHH

TENM2 TENM4

8.01e-0442182PF15636
DomainCOA_CT_CTER

ACACA ACACB

8.01e-0442182PS50989
DomainCOA_CT_NTER

ACACA ACACB

8.01e-0442182PS50980
DomainTen_N

TENM2 TENM4

8.01e-0442182IPR009471
DomainTen_N

TENM2 TENM4

8.01e-0442182PF06484
DomainVPS13_C

VPS13C VPS13D

8.01e-0442182PF16909
DomainCOA_CT_N

ACACA ACACB

8.01e-0442182IPR011762
DomainCOA_CT_C

ACACA ACACB

8.01e-0442182IPR011763
DomainVPS13_C

VPS13C VPS13D

8.01e-0442182IPR031645
DomainTENEURIN_N

TENM2 TENM4

8.01e-0442182PS51361
DomainSHR-BD

VPS13C VPS13D

8.01e-0442182PF06650
DomainCarboxyl_trans

ACACA ACACB

8.01e-0442182IPR000022
DomainACTINS_2

ACTA1 ACTA2 ACTC1

9.45e-04172183PS00432
DomainLaminin_EGF

HSPG2 LAMA2 LAMA5 CELSR3

9.76e-04382184IPR002049
DomainActin/actin-like_CS

ACTA1 ACTA2 ACTC1

1.12e-03182183IPR020902
DomainACTINS_ACT_LIKE

ACTA1 ACTA2 ACTC1

1.32e-03192183PS01132
DomainBiotin_BS

ACACA ACACB

1.33e-0352182IPR001882
DomainLaminin_domII

LAMA2 LAMA5

1.33e-0352182IPR010307
DomainBiotin_COase_C

ACACA ACACB

1.33e-0352182IPR005482
DomainYD

TENM2 TENM4

1.33e-0352182IPR006530
DomainBC

ACACA ACACB

1.33e-0352182PS50979
DomainLaminin_aI

LAMA2 LAMA5

1.33e-0352182IPR009254
DomainLaminin_I

LAMA2 LAMA5

1.33e-0352182PF06008
DomainLaminin_II

LAMA2 LAMA5

1.33e-0352182PF06009
DomainBiotin_carb_C

ACACA ACACB

1.33e-0352182SM00878
DomainBiotin_carb_C

ACACA ACACB

1.33e-0352182PF02785
DomainBiotin_carboxylation_dom

ACACA ACACB

1.33e-0352182IPR011764
DomainCPSASE_1

ACACA ACACB

1.33e-0352182PS00866
DomainBIOTIN

ACACA ACACB

1.33e-0352182PS00188
DomainIG

SIGLEC8 SPEG CNTN6 HAVCR1 CILP2 PXDN FGFR1 KIR3DL2 HSPG2 OBSL1 PAPLN FCRL5 CEACAM20

1.40e-0342121813SM00409
DomainIg_sub

SIGLEC8 SPEG CNTN6 HAVCR1 CILP2 PXDN FGFR1 KIR3DL2 HSPG2 OBSL1 PAPLN FCRL5 CEACAM20

1.40e-0342121813IPR003599
DomainIG_LIKE

SIGLEC8 SPEG CNTN6 HAVCR1 CILP2 PXDN FGFR1 KIR3DL2 TAPBP HSPG2 OBSL1 PAPLN FCRL5 CEACAM20

1.95e-0349121814PS50835
DomainRudment_hybrid_motif

ACACA ACACB

1.97e-0362182IPR011054
DomainCPSASE_2

ACACA ACACB

1.97e-0362182PS00867
DomainEPHD

KMT2A TCF20 KDM4A

2.05e-03222183PS51805
DomainIg-like_dom

SIGLEC8 SPEG CNTN6 HAVCR1 CILP2 PXDN FGFR1 KIR3DL2 TAPBP HSPG2 OBSL1 PAPLN FCRL5 CEACAM20

2.43e-0350321814IPR007110
DomainPeptidase_M13_C

MME ECE1

2.74e-0372182IPR018497
DomainPeptidase_M13

MME ECE1

2.74e-0372182IPR000718
DomainPeptidase_M13_N

MME ECE1

2.74e-0372182PF05649
DomainCbamoylP_synth_lsu-like_ATP-bd

ACACA ACACB

2.74e-0372182IPR005479
DomainPeptidase_M13_N

MME ECE1

2.74e-0372182IPR008753
DomainBC-like_N

ACACA ACACB

2.74e-0372182IPR005481
DomainCPSase_L_D2

ACACA ACACB

2.74e-0372182PF02786
DomainPeptidase_M13

MME ECE1

2.74e-0372182PF01431
PathwayKEGG_ECM_RECEPTOR_INTERACTION

DAG1 HSPG2 COL11A2 FN1 COMP LAMA2 LAMA5 TNR

2.10e-06841438M7098
PathwayREACTOME_ECM_PROTEOGLYCANS

DAG1 HSPG2 FN1 COMP LAMA2 LAMA5 TNR

1.16e-05761437M27219
PathwayREACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS

DAG1 HSPG2 COL11A2 FN1 LAMA2 LAMA5

2.84e-05591436M27218
PathwayWP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING

ACACA JAK3 PIK3C2B FGFR1 NOS2 COL11A2 FN1 COMP LAMA2 LAMA5 TNR SOS1

5.85e-0530214312M39719
PathwayWP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING

ACACA ACTA2 FGFR1 KLK15 FN1 TJP1 SMAD9

1.13e-041081437M48078
PathwayWP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY

ACACA JAK3 PIK3C2B FGFR1 NOS2 COL11A2 FN1 COMP LAMA2 LAMA5 TNR SOS1

1.21e-0432614312MM15917
PathwayKEGG_FOCAL_ADHESION

MYLK3 VASP COL11A2 FN1 COMP LAMA2 LAMA5 TNR SOS1

1.94e-041991439M7253
PathwayREACTOME_MET_ACTIVATES_PTK2_SIGNALING

COL11A2 FN1 LAMA2 LAMA5

2.27e-04301434M27772
PathwayREACTOME_LAMININ_INTERACTIONS

HSPG2 COL7A1 LAMA2 LAMA5

2.27e-04301434M27216
PathwayREACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION

DAG1 PXDN HSPG2 COL7A1 COL11A2 FN1 COMP ADAMTS1 LAMA2 LAMA5 TNR

2.42e-0430014311M610
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

TANC2 ABCC3 NR2F6 ACACA BCAS3 SPEG CUL9 ANKLE1 WNK1 JAK3 ZC3H11A PER2 NFATC1 PIK3C2B SGSM2 SNX15 FGFR1 HOXB13 HSPG2 FRAS1 SHROOM3 KHNYN LAMA5 GEMIN5 PAPLN MIB2 BTAF1 MLXIP ECE1 CDC42BPB ARHGEF10L NCOR2 CELSR3 KANK3

4.34e-1411052243435748872
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SPEG CUL9 TENM2 SNX19 STRIP2 ZC3H11A KIDINS220 PXDN PER2 SGSM2 CHD6 FRAS1 TCF20 ZSWIM5 KHNYN OBSL1 MLXIP TENM4 TCF25 ACIN1

2.86e-124072242012693553
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

TANC2 ACACA BCAS3 WNK1 PTER ITPKB KIAA0753 DLC1 MYLK3 PIK3C2B PRMT5 KMT2A KIF11 MIIP SHROOM3 ARHGEF28 TCF20 HNRNPUL1 MLXIP MAP7 VPS13D TJP1 RAB11FIP5 CEP152

2.19e-098612242436931259
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

KLF12 ACACB ZBTB48 APC2 WNK1 SYNGAP1 AEBP1 GLI2 SCN10A VASP SHROOM3 NCOR2 USF3 PLCH2 AJUBA SOS1

2.41e-084302241635044719
Pubmed

The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.

SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1

2.49e-086224420850414
Pubmed

Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.

SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1

2.49e-086224425930072
Pubmed

Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.

HSPG2 COL7A1 FRAS1 FN1 LAMA2 LAMA5

2.80e-0829224622613833
Pubmed

Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma.

ACTA1 ACTC1 MIB2

2.64e-073224314507647
Pubmed

Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization.

ACTA1 ACTA2 ACTC1

2.64e-07322437780165
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

HEXB ZBTB38 STUB1 APC2 CUL9 ZNF202 SYNGAP1 DGLUCY SGSM2 CHD6 QARS1 FN1 ADAMTS1 SYNM CNTNAP1 OBSL1 HNRNPUL1 PDCD7 CDC42BPB CRMP1 CELSR3 TJP1 DCTN6 LRP2 KDM4A SOS1

2.83e-0712852242635914814
Pubmed

Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.

DAG1 LRG1 AEBP1 AHSG HSPG2 FN1 COMP LAMA2 LAMA5

4.89e-07146224927068509
Pubmed

FRS2α-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity.

ACTA1 ACTA2 ACTC1 FGFR1

5.34e-0711224422207710
Pubmed

Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation.

ACTA2 FAT4 TJP1 DCHS1

5.34e-0711224426114487
Pubmed

Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.

ACTA1 ACTA2 ACTC1 LAMA2 LAMA5

6.24e-0726224524742657
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

HEXB TANC2 BCAS3 ACTA1 SNAP47 MRPS22 ITPKB SYNGAP1 NWD2 KIDINS220 PRMT5 KMT2A CKMT1A FN1 DOCK8 PCLO CNTNAP1 GEMIN5 MAP7 CDC42BPB CRMP1 KHSRP CORO1A TENM4 TJP1 TNR TNS1

6.41e-0714312242737142655
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

KLF12 ERCC4 DAG1 DHDDS WNK1 KIAA0753 HAVCR1 ZC3H11A ERAL1 FMN1 TMX3 USF2 TAPBP KIF11 FN1 RCCD1 GEMIN5 PTPN23 ATXN1L CRMP1 LRP2 ACIN1 TNS1

6.44e-0710842242311544199
Pubmed

Transcriptome-based systematic identification of extracellular matrix proteins.

VIT HSPG2 COL7A1 FRAS1 LAMA2 LAMA5 PAPLN

8.19e-0779224718757743
Pubmed

Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin.

DAG1 HSPG2 CNTNAP1

1.05e-064224325646087
Pubmed

An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.

DAG1 LAMA2 LAMA5

1.05e-064224311565031
Pubmed

Deletion of astroglial connexins weakens the blood-brain barrier.

DAG1 HSPG2 FN1 TJP1

1.59e-0614224422472609
Pubmed

Sonic hedgehog-dependent synthesis of laminin alpha1 controls basement membrane assembly in the myotome.

DAG1 GLI2 HSPG2 LAMA5

1.59e-0614224419783738
Pubmed

Tie1 is required for lymphatic valve and collecting vessel development.

ACTA2 NFATC1 LAMA5 ENG

1.59e-0614224425576926
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

DAG1 CUL9 PIK3C2B AHSG SLC23A1 CCR10 CNTNAP1 KHSRP CELSR3 APOL5 LRP2 SOS1

1.74e-063292241217474147
Pubmed

A census of human transcription factors: function, expression and evolution.

KLF12 NR2F6 ZBTB38 ZBTB48 ZNF202 ZC3H11A NFATC1 GLI2 KMT2A USF2 HSF4 HOXB13 NPAS1 ISL2 POU3F3 MLXIP USF3 DMRTB1 PROP1 SMAD9

2.05e-069082242019274049
Pubmed

POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.

FMN1 PRMT5 PKHD1 CHD6 KIF11 SHROOM3 PCLO PCDH11Y VPS13D RP1 SOS1

2.09e-062772241130745168
Pubmed

Severe protein aggregate myopathy in a knockout mouse model points to an essential role of cofilin2 in sarcomeric actin exchange and muscle maintenance.

ACTA1 ACTA2 DAG1 ACTC1

2.16e-0615224424598388
Pubmed

Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.

KLF12 ERN1 DAG1 GLI2 FGFR1 SHROOM3 MAP7 NCOR2 VPS13D TENM4 KANK3 KDM4A CEP152 KAT6B SOS1

2.41e-065362241515840001
Pubmed

Exchangeable gene trap using the Cre/mutated lox system.

KLF12 ERN1 DAG1 GLI2 FGFR1 SHROOM3 MAP7 NCOR2 VPS13D TENM4 KANK3 KDM4A CEP152 KAT6B SOS1

2.53e-065382241510512203
Pubmed

Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1.

FN1 ADAMTS1 DCHS1

2.61e-065224316061471
Pubmed

Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.

DAG1 HSPG2 FN1 LAMA2

2.87e-0616224417948866
Pubmed

Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice.

HSPG2 FN1 LAMA2 TJP1

2.87e-0616224411564885
Pubmed

Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis.

GLI2 HSPG2 COL7A1 LAMA5 SMAD9

2.94e-0635224518676816
Pubmed

The cleavage of host cell proteins by HIV-1 protease.

ACTA1 ACTA2 ACTC1 FN1

3.73e-061722448997639
Pubmed

Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation.

ACTA2 NFATC1 HSPG2 FN1 ADAMTS1

4.47e-0638224529743679
Pubmed

Pax6-dependent Shroom3 expression regulates apical constriction during lens placode invagination.

VASP SHROOM3 TJP1

5.20e-066224320081189
Pubmed

Virus assembly and plasma membrane domains: which came first?

ACTA1 ACTA2 ACTC1

5.20e-066224322989508
Pubmed

Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants.

ACTA1 ACTA2 ACTC1

5.20e-066224312009869
Pubmed

Mammalian Fat and Dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex.

FAT4 TJP1 DCHS1

5.20e-066224319506035
Pubmed

HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.

ACTA1 ACTA2 ACTC1

5.20e-066224323811015
Pubmed

Retroviral assembly and budding occur through an actin-driven mechanism.

ACTA1 ACTA2 ACTC1

5.20e-066224319883584
Pubmed

Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells.

ACTA1 ACTA2 ACTC1

5.20e-066224321917091
Pubmed

HIV-1 Gag protein associates with F-actin present in microfilaments.

ACTA1 ACTA2 ACTC1

5.20e-06622438661406
Pubmed

A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.

ACTA1 ACTA2 ACTC1

5.20e-066224323017337
Pubmed

Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton.

ACTA1 ACTA2 ACTC1

5.20e-06622439841925
Pubmed

Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.

ACTA1 ACTA2 ACTC1

5.20e-06622439971772
Pubmed

Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin.

ACTA1 ACTA2 ACTC1

5.20e-066224310074138
Pubmed

HIV-1 protease cleaves actin during acute infection of human T-lymphocytes.

ACTA1 ACTA2 ACTC1

5.20e-06622431540415
Pubmed

HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility.

ACTA1 ACTA2 ACTC1

5.20e-066224311709093
Pubmed

Tagging the human immunodeficiency virus gag protein with green fluorescent protein. Minimal evidence for colocalisation with actin.

ACTA1 ACTA2 ACTC1

5.20e-066224310049817
Pubmed

Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.

ACTA1 ACTA2 ACTC1

5.20e-066224323875777
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

STUB1 APC2 ACTA1 ACTA2 ACTC1 STRIP2 AHSG FAT4 FRAS1 PCDHGC5 HNRNPUL1 KHSRP CELSR3 CNGB3

7.00e-065132241425798074
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

TANC2 ACACB ACTA1 SAV1 WNK1 KIAA0753 QARS1 SHROOM3 DOCK8 IFFO1 KIF7 TJP1 CEP152

7.45e-064462241324255178
Pubmed

Fgf9 signaling regulates small intestinal elongation and mesenchymal development.

ACTA2 FGFR1 ENG SMAD9

7.48e-0620224418653563
Pubmed

The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry.

ACTA1 ACTA2 ACTC1

9.05e-067224322535526
Pubmed

Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice.

SPEG ACTA1 ACTC1

9.05e-067224319118250
Pubmed

Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.

FAT2 FAT4 DCHS1

9.05e-067224316059920
Pubmed

HIV-1 replication from after cell entry to the nuclear periphery.

ACTA1 ACTA2 ACTC1

9.05e-067224317504171
Pubmed

Disruption of anterior segment development by TGF-beta1 overexpression in the eyes of transgenic mice.

ACTA2 HSPG2 FN1

9.05e-067224312242711
Pubmed

Distinct alpha 7A beta 1 and alpha 7B beta 1 integrin expression patterns during mouse development: alpha 7A is restricted to skeletal muscle but alpha 7B is expressed in striated muscle, vasculature, and nervous system.

DAG1 LAMA2 ENG

9.05e-06722438950511
Pubmed

Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.

DAG1 HSPG2 LAMA2

9.05e-067224311802174
Pubmed

alpha3beta1 Integrin is required for normal development of the epidermal basement membrane.

COL7A1 FN1 LAMA5

9.05e-06722439151677
Pubmed

Selective targeting of ITK blocks multiple steps of HIV replication.

ACTA1 ACTA2 ACTC1

9.05e-067224318443296
Pubmed

The trinity of the cortical actin in the initiation of HIV-1 infection.

ACTA1 ACTA2 ACTC1

9.05e-067224322640593
Pubmed

siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.

ACTA1 ACTA2 ACTC1

9.05e-067224322465675
Pubmed

Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.

ACTA1 ACTA2 ACTC1

9.05e-06722439384381
Pubmed

A Novel Mouse Model for Cilia-Associated Cardiovascular Anomalies with a High Penetrance of Total Anomalous Pulmonary Venous Return.

ACTA1 ACTA2 ACTC1

9.05e-067224330289203
Pubmed

Schwann cell myelination requires integration of laminin activities.

DAG1 HSPG2 LAMA2 LAMA5

9.20e-0621224422767514
Pubmed

DOT1L regulates dystrophin expression and is critical for cardiac function.

ACTA1 DAG1 HSPG2 SGCA

9.20e-0621224421289070
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

ABCC3 BCAS3 CUL9 SGSM2 HSPG2 FN1 LAMA5 ECE1 MRPL39

1.13e-05214224922199357
Pubmed

TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.

PXDN TMX3 HSPG2 FRAS1 LAMA5 ECE1 CNNM3 TENM4

1.21e-05164224832409323
Pubmed

The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.

PXDN HSPG2 COL7A1 FRAS1 FN1 LAMA2 LAMA5 PAPLN

1.37e-05167224822159717
Pubmed

Cloning and expression analyses of mouse dystroglycan gene: specific expression in maternal decidua at the peri-implantation stage.

DAG1 LAMA2 LAMA5

1.44e-05822438872465
Pubmed

Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.

ACTA1 ACTA2 ACTC1

1.44e-058224320147394
Pubmed

Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization.

ACTA1 ACTA2 ACTC1

1.44e-058224323260110
Pubmed

Mouse AMACO, a kidney and skin basement membrane associated molecule that mediates RGD-dependent cell attachment.

COL7A1 FN1 LAMA5

1.44e-058224319651211
Pubmed

Fibulin-1 is required for morphogenesis of neural crest-derived structures.

ACTA1 ACTA2 FN1

1.44e-058224318538758
Pubmed

Caveolin-3 deficiency causes muscle degeneration in mice.

DAG1 SGCA LAMA2

1.44e-058224311115849
Pubmed

Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice.

COL7A1 FRAS1 LAMA5

1.44e-058224312766770
Pubmed

Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.

ACTA1 ACTA2 ACTC1

1.44e-058224320096780
Pubmed

Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production.

ACTA1 ACTA2 ACTC1

1.44e-058224314694110
Pubmed

Sox4-deficiency syndrome in mice is an animal model for common trunk.

ACTA2 ACTC1 FN1

1.44e-05822439815146
Pubmed

Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.

SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1

1.61e-0524224432212159
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TANC2 APC2 TENM2 SYNGAP1 KIF11 SHROOM3 TCF20 CNTNAP1 PAF1 CDC42BPB SHISA7 CRMP1 KHSRP KIF7 NCOR2 TJP1 DCHS1 TNR TNS1

1.75e-059632241928671696
Pubmed

Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis.

HSPG2 FN1 LAMA2 LAMA5

1.91e-0525224419373938
Pubmed

Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.

FN1 LAMA2 LAMA5

2.15e-05922439882526
Pubmed

Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.

FAT4 FN1 DCHS1

2.15e-059224328705793
Pubmed

Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF.

ACTA1 ACTA2 ACTC1

2.15e-059224310556093
Pubmed

Modulation of cardiac growth and development by HOP, an unusual homeodomain protein.

ACTA1 ACTA2 ACTC1

2.15e-059224312297046
Pubmed

Hepatocyte nuclear factor 4 alpha is associated with mesenchymal-epithelial transition in developing kidneys of C57BL/6 mice.

ACTA1 FN1 TJP1

2.15e-059224321186337
Pubmed

Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.

ACTA1 ACTA2 ACTC1

2.15e-05922438892894
Pubmed

HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells.

ACTA1 ACTA2 ACTC1

2.15e-059224318775311
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

ACACA ACACB SPEG SYNGAP1 PIK3C2B KMT2A QARS1 TAPBP CKMT1A FN1 VPS13D KDM4A RP1

2.32e-054972241336774506
Pubmed

MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.

STUB1 ZC3H11A GLI2 PRMT5 FGFR1 QARS1 VASP PHRF1 ISL2 KHSRP ACIN1

2.34e-053582241132460013
Pubmed

An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.

ACACA ACACB RBM12B DAG1 SHROOM3 TCF20 KHSRP NCOR2

2.36e-05180224835198878
Pubmed

Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.

AEBP1 HSPG2 COL7A1 COL11A2 FN1 LAMA2 LAMA5

2.88e-05135224728675934
Pubmed

Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.

ACTA1 ACTA2 ACTC1

3.06e-051022431907279
Pubmed

Primary cellular meningeal defects cause neocortical dysplasia and dyslamination.

DAG1 LAMA2 LAMA5

3.06e-0510224320976766
Pubmed

Non-viral cellular substrates for human immunodeficiency virus type 1 protease.

ACTA1 ACTA2 ACTC1

3.06e-051022431991513
Pubmed

Gelsolin activity controls efficient early HIV-1 infection.

ACTA1 ACTA2 ACTC1

3.06e-0510224323575248
Pubmed

Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.

ACTA1 ACTA2 ACTC1

3.06e-0510224321749862
InteractionTOP3B interactions

TANC2 ABCC3 NR2F6 ACACA BCAS3 SPEG CUL9 ANKLE1 WNK1 JAK3 ZC3H11A PER2 NFATC1 PIK3C2B SGSM2 PRMT5 AHSG SNX15 FGFR1 QARS1 HOXB13 HSPG2 FRAS1 SHROOM3 KHNYN LAMA5 GEMIN5 PAPLN MIB2 BTAF1 MLXIP ECE1 CDC42BPB ARHGEF10L NCOR2 CELSR3 KANK3 ACIN1 KDM4A

2.23e-07147022139int:TOP3B
InteractionFBXO2 interactions

HEXB STUB1 DAG1 SYNGAP1 CILP2 PXDN AHSG FGFR1 TAPBP HSPG2 FRAS1 NPTX2 FN1 CNTNAP1 LAMA5 ECE1 CELSR3 LRP2

7.09e-0741122118int:FBXO2
InteractionZYX interactions

TANC2 ACTA2 ACTC1 WNK1 KIDINS220 FGFR1 VASP SHROOM3 FN1 SYNM OBSL1 PTPN23 MLXIP TJP1 CEP152 AJUBA

7.67e-0732922116int:ZYX
InteractionPFN1 interactions

STUB1 VPS13C ACTA1 ACTA2 ACTC1 WNK1 KIDINS220 QARS1 WIPF2 VASP KIF11 FN1 DOCK8 PCLO OBSL1 CRMP1 KIF7 TJP1 CEP152

3.68e-0650922119int:PFN1
InteractionLLCFC1 interactions

ZBTB48 PXDN FGFR1 FAT4 CNTNAP1 LAMA5 ECE1 CELSR3 DCHS1

7.61e-061212219int:LLCFC1
InteractionNPTXR interactions

ACACA ACACB NPTX2 FN1 CORO1A

1.01e-05272215int:NPTXR
InteractionPLEC interactions

ACTA1 ACTA2 ACTC1 WNK1 PER2 PRMT5 FGFR1 QARS1 NOS2 FN1 TEDC2 OBSL1 LAMA5 CORO1A TJP1 SMAD9

2.29e-0543022116int:PLEC
InteractionDCANP1 interactions

FAT4 SPPL3 CELSR3 DCHS1

4.79e-05192214int:DCANP1
InteractionCCL19 interactions

CCR10 FAT4 DCTN6 KDM4A

4.79e-05192214int:CCL19
InteractionKLHL2 interactions

ACTC1 WNK1 PIK3C2B OBSL1 DCTN6 TCF25 ACIN1

5.58e-05892217int:KLHL2
GeneFamilyCadherin related

CDH23 FAT2 FAT4 DCHS1

8.47e-0617144424
GeneFamilyActins

ACTA1 ACTA2 ACTC1

9.72e-0661443929
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

SPEG CNTN6 PXDN FGFR1 HSPG2 OBSL1 PAPLN CEACAM20

4.49e-051611448593
CoexpressionNABA_CORE_MATRISOME

VIT LRG1 CILP2 FNDC7 PXDN AEBP1 HSPG2 COL7A1 FRAS1 COL11A2 FN1 COMP LAMA2 LAMA5 CDCP2 PAPLN TNR

1.89e-1027022317MM17057
CoexpressionNABA_CORE_MATRISOME

VIT LRG1 CILP2 FNDC7 PXDN AEBP1 HSPG2 COL7A1 FRAS1 COL11A2 FN1 COMP LAMA2 LAMA5 CDCP2 PAPLN TNR

2.51e-1027522317M5884
CoexpressionNABA_ECM_GLYCOPROTEINS

VIT LRG1 CILP2 FNDC7 PXDN AEBP1 FRAS1 FN1 COMP LAMA2 LAMA5 CDCP2 PAPLN TNR

1.11e-0919122314MM17059
CoexpressionNABA_ECM_GLYCOPROTEINS

VIT LRG1 CILP2 FNDC7 PXDN AEBP1 FRAS1 FN1 COMP LAMA2 LAMA5 CDCP2 PAPLN TNR

1.56e-0919622314M3008
CoexpressionLAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM

TANC2 ACACB TENM2 FMN1 CHD6 MME FRAS1 TENT5A SPPL3 TENM4 TCF25 LRP2 ACIN1 KAT6B TNS1

3.23e-0641722315M39224
CoexpressionGSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP

ACACA STUB1 CUL9 ARHGEF28 TENT5A PCLO PCDH11Y KIAA1614 AJUBA ENG

5.96e-0619122310M3298
CoexpressionGAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS

DLC1 FGFR1 ADAMTS1 IFFO1 LAMA2 CPZ ATXN1L CRMP1 TENM4 DCHS1

1.26e-0520822310M39139
CoexpressionPHONG_TNF_RESPONSE_VIA_P38_COMPLETE

ACACA KMT2A TCF20 SYNM PCLO OBSL1 MLXIP JRK KAT6B SOS1

2.38e-0522422310M2500
CoexpressionBERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN

SPEG ACTA2 SAV1 KIDINS220 DLC1 HSPG2 OBSL1 LAMA2 EFR3B

2.52e-051802239M10605
CoexpressionDESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS

HEXB CILP2 FAT2 NOS2 HSPG2 FN1

2.95e-05702236M40277
CoexpressionGSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP

STRIP2 SCN10A HOXB13 ARHGEF28 ZSWIM5 DUOX2 ISL2 PAPLN DMRTB1

3.55e-051882239M7940
CoexpressionDESCARTES_ORGANOGENESIS_CHOLINERGIC_NEURONS

TANC2 NWD2 DLC1 NPTX2 CRMP1 TNR

4.72e-05762236MM3658
CoexpressionGSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN

NR2F6 ZBTB48 IFFO1 MIB2 ARHGEF10L CELSR3 KANK3 KAT6B

5.97e-051562238M6865
CoexpressionLASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN

ZBTB48 ZNF202 DHDDS SNX19 FBXO42 KMT2A QARS1 KIF11 MIIP ZSWIM5 MIB2 BTAF1 ECE1 ARHGEF10L CRMP1 VPS13D TENM4 KDM4A KAT6B

6.68e-0580722319M14594
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DLC1 NFATC1 AEBP1 GLI2 FAT4 FN1 COMP TENT5A LAMA2 ATP10D

2.26e-08176224109bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DLC1 NFATC1 AEBP1 GLI2 FAT4 FN1 COMP TENT5A LAMA2 ATP10D

2.26e-08176224103f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9

SIGLEC8 USF2 MIIP SYNM DOCK8 PAF1 ARHGEF10L ZNHIT6 CARD11

1.40e-071622249810881210e015c788814e4fe8d7a24c929cf2621
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TANC2 FMN1 SHROOM3 ARHGEF28 TENT5A OBSL1 MAP7 MBIP TENM4

3.26e-071792249fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCellCOVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type

HAVCR1 PKHD1 FRAS1 ARHGEF28 PCLO POU3F3 MAP7 LRP2 CDH9

3.75e-0718222499d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TANC2 FMN1 SHROOM3 ARHGEF28 TENT5A OBSL1 MAP7 MBIP TENM4

3.75e-07182224917ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCellLPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRG1 FMN1 SHROOM3 ARHGEF28 TENT5A OBSL1 MAP7 MBIP TENM4

3.93e-071832249e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TANC2 FMN1 MME SHROOM3 ARHGEF28 OBSL1 MAP7 MBIP TENM4

4.11e-071842249ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRG1 FMN1 SHROOM3 ARHGEF28 TENT5A OBSL1 MAP7 MBIP TENM4

4.30e-071852249fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SPEG ACTA2 NFATC1 GLI2 FGFR1 ADAMTS1 ECE1 ELL2 TNS1

4.30e-071852249e58a009aaf342be019a909747b1895d5987d4daf
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TANC2 ERN1 FMN1 SHROOM3 ARHGEF28 TENT5A MAP7 MBIP TENM4

4.50e-071862249e83718fabb057100835d3357df407f283d23fe16
ToppCellCOVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type

HAVCR1 PKHD1 FRAS1 ARHGEF28 PCLO POU3F3 MAP7 LRP2 CDH9

4.71e-071872249d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TANC2 ERN1 FMN1 SHROOM3 ARHGEF28 TENT5A MAP7 MBIP TENM4

4.93e-0718822494bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCelldroplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACTA1 DLC1 SYNM LAMA5 ECE1 TJP1 KANK3 ENG TNS1

4.93e-0718822495cf060bb8adaefa9964187195d67993c1248ef47
ToppCelldroplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACTA1 DLC1 SYNM LAMA5 ECE1 TJP1 KANK3 ENG TNS1

4.93e-071882249e901a9bdf00b8e91806f445af66647373bf62661
ToppCelldroplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACTA1 DLC1 SYNM LAMA5 ECE1 TJP1 KANK3 ENG TNS1

4.93e-071882249449f9602df3c83b2110eb479a00d428d1b55b423
ToppCellCOVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type

SPEG ACTA2 ACTC1 DLC1 AEBP1 GLI2 SYNM SGCA ELL2

5.63e-071912249fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 MME FRAS1 SHROOM3 ARHGEF28 PCLO MAP7 ARHGEF10L LRP2

6.14e-07193224982e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

SPEG ACTA1 ACTA2 ACTC1 VASP ADAMTS1 SYNM SGCA LAMA5

6.98e-071962249541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ACTA2 DLC1 AEBP1 GLI2 FN1 ADAMTS1 TENT5A LAMA2 ATP10D

6.98e-0719622493a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ACTA2 DLC1 AEBP1 GLI2 FN1 ADAMTS1 TENT5A LAMA2 ATP10D

6.98e-071962249bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DLC1 PXDN NFATC1 AEBP1 GLI2 FAT4 FN1 LAMA2 ATP10D

7.29e-07197224985a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DLC1 NFATC1 AEBP1 GLI2 FGFR1 FAT4 FN1 LAMA2 ENG

7.29e-0719722499b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SPEG ACTA2 ACTC1 AEBP1 ADAMTS1 SYNM SGCA LAMA5 KANK3

7.29e-0719722490f9836554ace3f9d155ebafdd719aa26466ca44e
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DLC1 PXDN NFATC1 AEBP1 GLI2 FAT4 FN1 LAMA2 ATP10D

7.29e-071972249e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SPEG ACTA2 ACTC1 AEBP1 ADAMTS1 SYNM SGCA LAMA5 KANK3

7.29e-07197224971367bebc23d0e81f60f780d6b0ab3a1783ac014
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells)

SPEG ACTA1 ACTA2 ACTC1 AEBP1 REM1 FN1 ADAMTS1 SGCA

7.60e-071982249c82a151f9f1477d4a401457173b8d72af776c137
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells)

SPEG ACTA1 ACTA2 ACTC1 AEBP1 REM1 FN1 ADAMTS1 SGCA

7.60e-071982249dc63b56bb6291e527b172d603569376286262845
ToppCellTracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FAM170A TMEM130 CILP2 NFATC1 AEBP1 COL11A2 FN1 COMP POU3F3

7.60e-071982249c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc
ToppCellTracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FAM170A TMEM130 CILP2 NFATC1 AEBP1 COL11A2 FN1 COMP POU3F3

7.60e-07198224955f013e9e6587d9ece59751fa131b1d22d6cceea
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPEG ACTA2 LRG1 PXDN AEBP1 FN1 ADAMTS1 SYNM ARHGEF10L

7.93e-071992249b1753474152b82a0b811b9878c890a359e14919a
ToppCellFrontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

TANC2 SNAP47 TMEM130 CKMT1A PCLO CRMP1 CELSR3 TCF25 SRRM3

7.93e-071992249f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CILP2 DLC1 AEBP1 FGFR1 FAT4 FN1 COMP PCDH11Y LAMA2

8.26e-072002249a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SPEG ACTA1 ACTA2 ACTC1 VASP ADAMTS1 SYNM SGCA TNS1

8.26e-0720022498b80a65b69b36ed405214564b939452c90aa40d6
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SPEG ACTA1 ACTA2 ACTC1 VASP ADAMTS1 SYNM SGCA TNS1

8.26e-0720022492bc7f462a551292de2501028164573935232f899
ToppCellfacs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAM170A TENM2 NFATC1 GLI2 FGFR1 FCRL5 TNS1 CDH9

1.87e-0616422487a65c7a6dbe5fb9067f83efafbb7ec8206d79325
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CNTN6 AEBP1 PKHD1 FRAS1 PCLO CNGB3 LRP2 RP1

2.34e-06169224812bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CILP2 AEBP1 GLI2 FGFR1 HSPG2 FAT4 TENT5A LAMA2

2.55e-061712248972fab891135bd755d5526cbc5a963200067b0a6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CILP2 AEBP1 GLI2 FGFR1 HSPG2 FAT4 TENT5A LAMA2

2.55e-0617122482a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ACTA2 AEBP1 FAT4 COMP ADAMTS1 LAMA2 PAPLN TNS1

3.03e-0617522481799a7be623dc3bf53ba580a7c47d2619969d708
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

ACTA2 ACTC1 AEBP1 REM1 ADAMTS1 SYNM SGCA TMEM132E

3.03e-061752248fed9e4120c758fdcc23bb248d1801002b0e0d485
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DLC1 FGFR1 HSPG2 FN1 ECE1 KANK3 DCHS1 ENG

3.44e-061782248375156ba1c7b8592bf733c75f24968161f7cfa09
ToppCellCOPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class

SPEG ACTA2 ACTC1 AEBP1 ADAMTS1 SYNM SGCA TNS1

3.58e-0617922485c705627bd13a5b2c7b0062fb3d94e4eb1589327
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRG1 FMN1 MME SHROOM3 ARHGEF28 TENT5A MAP7 MBIP

3.73e-061802248b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCellMatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4)

VPS13C DLC1 MME REM1 FN1 ADAMTS1 SYNM TNS1

3.73e-061802248adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYLK3 AEBP1 SGSM2 FRAS1 CNTNAP1 PAPLN DCTN6 LRP2

3.89e-061812248330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCellLPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRG1 FMN1 SHROOM3 ARHGEF28 TENT5A MAP7 MBIP TENM4

3.89e-0618122480513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYLK3 AEBP1 SGSM2 FRAS1 CNTNAP1 PAPLN DCTN6 LRP2

3.89e-0618122483f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

NOS2 HSPG2 ARHGEF28 TJP1 KANK3 DCHS1 ENG TNR

4.05e-061822248997d37ca2af661c92a56add888762724dfccc890
ToppCellCOVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type

ABCC3 HAVCR1 PKHD1 FRAS1 ARHGEF28 MAP7 LRP2 CDH9

4.22e-0618322486878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCellPericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id

SPEG ACTA2 AEBP1 REM1 ADAMTS1 SYNM SGCA DCHS1

4.39e-061842248cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ZBTB38 BCAS3 TMX3 SYNM ECE1 CRMP1 TJP1 KANK3

4.57e-061852248a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCellmoderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

UCN2 DLC1 AEBP1 COL7A1 FAT4 FN1 ADAMTS1 DCHS1

4.57e-0618522484979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCellTCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9

ACTA2 GLI2 NPTX2 REM1 FN1 SGCA APOL5 DCHS1

4.75e-0618622481e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ABCC3 ZBTB38 PTER HAVCR1 PKHD1 TENM4 LRP2 CDH9

4.75e-061862248b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTER CNTN6 PKHD1 FRAS1 SHROOM3 ARHGEF28 MAP7 MBIP

4.75e-0618622484e94158db52df41d71e67b02b9895a358eebee0f
ToppCellMesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor

ACTA2 AEBP1 GLI2 FAT4 FN1 ADAMTS1 LAMA2 TENM4

5.35e-06189224844e37f88137bb249933eb615235b2cf2ae7f3925
ToppCellMacrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

ABCC3 MME VASP ARHGEF28 FN1 DOCK8 ARHGEF10L DDIAS

5.35e-061892248c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCellmoderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

UCN2 DLC1 AEBP1 HSPG2 COL7A1 FAT4 FN1 ADAMTS1

5.35e-06189224822a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

JAK3 NFATC1 AEBP1 GLI2 FGFR1 FAT4 LAMA2 KIF7

5.56e-061902248048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

JAK3 NFATC1 AEBP1 GLI2 FGFR1 FAT4 LAMA2 KIF7

5.56e-0619022481121eb607a984c59fbffe7220837fc178745aa55
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ACTA2 DLC1 PXDN AEBP1 GLI2 FN1 TENT5A LAMA2

5.78e-061912248107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPEG ACTA1 ACTA2 ACTC1 AEBP1 FN1 ADAMTS1 SGCA

5.78e-0619122482a107e9096eb58b81b3da61547904d85754f6b2f
ToppCell10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

NOS2 HSPG2 ARHGEF28 LAMA5 TJP1 KANK3 DCHS1 ENG

5.78e-061912248cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPEG ACTA1 ACTA2 ACTC1 AEBP1 FN1 ADAMTS1 SGCA

5.78e-061912248d35692c652977500a3c36aa26c347a072b71e441
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACTA2 TENM2 AEBP1 ADAMTS1 SYNM NCOR2 PLCH2 TNS1

5.78e-0619122482f733d510a4862565a817f59829d8387d7ea26d9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ACTA2 DLC1 PXDN AEBP1 GLI2 FN1 TENT5A LAMA2

5.78e-061912248bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACTA2 TENM2 AEBP1 ADAMTS1 SYNM NCOR2 PLCH2 TNS1

5.78e-0619122488691eba35793e4e90f93d50c2145847ee51289f7
ToppCellfacs-BAT-Fat-18m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLC1 PXDN HSPG2 ECE1 TJP1 KANK3 ENG TNS1

6.00e-061922248f9777e0fdd86c2a514f05a42502888329a94b396
ToppCellfacs-BAT-Fat-18m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLC1 PXDN HSPG2 ECE1 TJP1 KANK3 ENG TNS1

6.00e-0619222483a99c521c599a289ee2309d97be5ceb99f8aa220
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ACTA2 AEBP1 GLI2 COL7A1 FN1 COMP LAMA2 TENM4

6.00e-06192224867e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCellPericytes|World / lung cells shred on cell class, cell subclass, sample id

SPEG ACTA2 ACTC1 AEBP1 REM1 ADAMTS1 SYNM SGCA

6.00e-061922248057ad22b878c0c5fb59ed1412ca13db945c57a5a
ToppCellfacs-BAT-Fat-18m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLC1 PXDN HSPG2 ECE1 TJP1 KANK3 ENG TNS1

6.00e-061922248562e15876088af9189744c9b2de5c4863d7f15fd
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NWD2 PKHD1 FRAS1 COMP DUOX2 CNGB3 CEACAM20 PIWIL3

6.24e-061932248315840bc48899f3a36d57b19197509de19716e3d
ToppCellfacs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ITPKB DLC1 HSPG2 ADAMTS1 TJP1 KANK3 ENG TNS1

6.24e-061932248e340064cd146deac03f2d0fd43e2e218bb6057c9
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CDH23 DLC1 PIK3C2B HSPG2 FN1 ECE1 KANK3 ENG

6.24e-061932248daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ACTA2 DLC1 AEBP1 GLI2 ADAMTS1 TENT5A LAMA2 ATP10D

6.24e-061932248c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CDH23 DLC1 HSPG2 ADAMTS1 LAMA5 DCHS1 RP1 ENG

6.24e-061932248c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9

CILP2 AEBP1 GLI2 FGFR1 CNTNAP1 CPZ CRMP1 TENM4

6.24e-061932248194e7fa00a50cc4e026987b715323d125d79594e
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 FRAS1 SHROOM3 ARHGEF28 PCLO MAP7 ARHGEF10L LRP2

6.24e-0619322483866667dd221612589ae50f5c52f73a183a49ce6
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ACTA2 DLC1 AEBP1 GLI2 ADAMTS1 TENT5A LAMA2 ATP10D

6.24e-0619322485b602b1702283184bd3943c2a6f2290b7c37e407
ToppCellfacs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ITPKB DLC1 HSPG2 ADAMTS1 TJP1 KANK3 ENG TNS1

6.24e-061932248a211b386fd0fb9da9937361d29d90925a72c9715
ToppCellfacs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ITPKB DLC1 HSPG2 ADAMTS1 TJP1 KANK3 ENG TNS1

6.24e-0619322483086c33f4d6fab66966818737f95ae4d6b2615b0
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ABCC3 VIT CILP2 FN1 SYNM PAPLN OCA2 SMAD9

6.48e-061942248f9fbb043411546d8c9e0321a64165d411f44aeb7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

JAK3 DLC1 PXDN AEBP1 GLI2 TENT5A LAMA2 ENG

6.48e-06194224881713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

JAK3 DLC1 PXDN AEBP1 GLI2 TENT5A LAMA2 ENG

6.48e-061942248627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ACTA2 AEBP1 FAT4 FN1 COMP ADAMTS1 SGCA LAMA2

6.48e-0619422488fae8061b350336299aa81f378e07deadbd55123
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ACTA2 DLC1 PXDN AEBP1 GLI2 TENT5A LAMA2 ENG

6.48e-061942248e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCellhuman_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

ZNF831 ITPKB JAK3 NFATC1 DOCK8 PLCH2 CARD11 FCRL5

6.48e-061942248997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ACTA2 AEBP1 FAT4 FN1 COMP ADAMTS1 SGCA LAMA2

6.48e-0619422484d7d24390fdb379f943ddcc70a63f23955e10163
ToppCelldroplet-Liver-LIVER-NPC-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLC1 PXDN HSPG2 ADAMTS1 TMEM132E KANK3 DCHS1 ENG

6.73e-061952248126f46dd15dddcf5701144718bb8ba1ce84b2d1d
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ABCC3 VIT CILP2 FN1 SYNM PAPLN OCA2 SMAD9

6.73e-0619522481be9502577267ca2a04656a99d57e3e2f124d92e
ToppCelldroplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACTA2 CILP2 PXDN PER2 HSPG2 COL11A2 CPZ TNS1

6.73e-061952248fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2
ToppCell10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ACTA2 PXDN MME HSPG2 COL7A1 FN1 LAMA2 TNS1

6.73e-06195224878cfde21dde4b877fc76c8b0d5ddaabe44b912d7
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TENM2 TMEM130 CKMT1A FRAS1 PCDHGC5 CRMP1 TENM4 RTL1

6.73e-061952248ffbab350e67d9c4b66c0ab84550daec8b8139a27
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PKHD1 FRAS1 SHROOM3 ARHGEF28 PCLO MAP7 ARHGEF10L RP1

6.73e-0619522486477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACTA2 ACTC1 AEBP1 FAT4 FN1 ADAMTS1 SGCA TNS1

6.73e-06195224844f67437ea65d530133a0240b17f9860d9cc0e99
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPEG ACTA2 DLC1 AEBP1 GLI2 FN1 TENT5A LAMA2

6.98e-061962248b8759e6231e0254797d6c30930407b79440c57bb
ToppCell10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ACTA2 DLC1 PXDN COL7A1 FN1 SGCA LAMA2 ECE1

6.98e-06196224812d9028f90c057c6e5cff00301793fa550e86c5a
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPEG ACTA1 ACTA2 ACTC1 AEBP1 ADAMTS1 SYNM SGCA

6.98e-06196224870b2e0b4ff4f1bc03fb72ace07a8a44f4b415922
ComputationalGenes in the cancer module 387.

SPEG ACTA1 ACTA2 ACTC1 AEBP1 LAMA2

2.90e-05491336MODULE_387
ComputationalGenes in the cancer module 329.

SPEG ACTA1 ACTA2 ACTC1 AEBP1 LAMA2

3.66e-05511336MODULE_329
DrugSulfanilamide [63-74-1]; Up 200; 23.2uM; PC3; HT_HG-U133A

SIGLEC8 DLC1 COL7A1 FN1 LAMA2 DDX51 MLXIP ECE1 CRMP1 DCHS1 ENG TNS1

3.80e-07194217124474_UP
Drugx C2

ERCC4 COMP SYNM

8.54e-0732173CID011705720
Drugkalinin

DHDDS USF2 HSPG2 COL7A1 FN1 LAMA2 LAMA5

8.93e-07552177CID000032518
DrugCimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A

SCN10A FGFR1 USF2 MIIP REM1 LAMA2 CRMP1 NCOR2 VPS13D MYO15A PROP1

2.88e-06195217111884_UP
DrugAmikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A

KLF12 SIGLEC8 JAK3 KIDINS220 FN1 COMP IFFO1 DUOX2 CNGB3 LRP2 TNS1

3.03e-06196217116715_UP
DrugRiboflavine [83-88-5]; Up 200; 10.6uM; PC3; HT_HG-U133A

KLF12 ZBTB38 DAG1 DLC1 AHSG ECE1 ZNF783 CELSR3 LRP2 CEP152 TNS1

3.51e-06199217114485_UP
DrugAzacyclonol [115-46-8]; Down 200; 15uM; PC3; HT_HG-U133A

ABCC3 ACACB SPEG KIDINS220 MIIP CNTNAP1 CDC42BPB NSUN3 TENM4 XPNPEP3 SOS1

3.68e-06200217116298_DN
DrugAC1Q6LQU

ACTA1 ACTA2 ACTC1 KIDINS220 FN1 TJP1

6.15e-06482176CID000072380
Drugfluorescein isothiocyanate

SIGLEC8 ACTA1 ACTA2 ACTC1 WNK1 MME FN1 TJP1 LRP2

1.21e-051472179CID000018730
DrugAC1L1HS4

ACTA1 ACTA2 ACTC1 FN1 TJP1

1.23e-05322175CID000004267
DrugMianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A

ABCC3 ERCC4 SPEG WNK1 DLC1 FN1 DDX51 FAM131A ECE1 EFR3B

1.44e-05189217102231_UP
DrugHydrocortisone base [50-23-7]; Up 200; 11uM; PC3; HT_HG-U133A

SIGLEC8 KIDINS220 AHSG FGFR1 LAMA2 DUOX2 OCA2 MLXIP TNS1 SMAD9

1.65e-05192217106684_UP
Drug2-deoxy-D-glucose; Down 200; 10000uM; MCF7; HG-U133A

KLF12 ERN1 WNK1 SNX19 REM1 IFFO1 TEDC2 ECE1 CORO1A TNS1

1.80e-0519421710344_DN
DrugCatechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A

ACACB SIGLEC8 APC2 FGFR1 ARHGEF28 FAM131A ECE1 VPS13D MYO15A TNS1

2.05e-05197217103351_UP
DrugCefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; PC3; HT_HG-U133A

ERN1 ACTA2 ACTC1 USF2 COL7A1 FAT4 FN1 LAMA2 CRMP1 CORO1A

2.05e-05197217105761_UP
Drug(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; PC3; HT_HG-U133A

NR2F6 SPEG SCN10A TEDC2 LAMA2 DDX51 CRMP1 CNGB3 TCF25 TNS1

2.15e-05198217105108_UP
DrugMiconazole [22916-47-8]; Down 200; 9.6uM; HL60; HG-U133A

DAG1 KIAA0753 JAK3 FBXO42 SCN10A SNX15 USF2 VASP FN1 KAT6B

2.15e-05198217101977_DN
DrugBezafibrate [41859-67-0]; Down 200; 11uM; HL60; HT_HG-U133A

FGFR1 USF2 WIPF2 VASP ARHGEF10L MTRF1 XPNPEP3 KAT6B ENG TNS1

2.15e-05198217101275_DN
DrugKawain [500-64-1]; Up 200; 17.4uM; HL60; HT_HG-U133A

ERCC4 SIGLEC8 ACTA1 COL7A1 ADAMTS1 IFFO1 KHSRP LRP2 RAB11FIP5 SOS1

2.24e-05199217102337_UP
DrugPentylenetetrazole [54-95-5]; Up 200; 29uM; PC3; HT_HG-U133A

ACTA1 DAG1 WNK1 GLI2 FGFR1 USF2 MIIP DUOX2 ZNF783 TENM4

2.24e-05199217102092_UP
DrugStachydrine hydrochloride; Up 200; 22.2uM; PC3; HT_HG-U133A

KLF12 SIGLEC8 JAK3 GLI2 REM1 IFFO1 MLXIP ECE1 VPS13D TNS1

2.34e-05200217104469_UP
DrugFamprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A

ABCC3 KLF12 ACTC1 COL7A1 FN1 DDX51 GYPB LRP2 ENG TNS1

2.34e-05200217106029_UP
DrugAminohippuric acid [61-78-9]; Up 200; 20.6uM; PC3; HT_HG-U133A

CUL9 PER2 FGFR1 REM1 CRMP1 KHSRP VPS13D CELSR3 CNGB3 SOS1

2.34e-05200217106294_UP
DrugBAY 41-2272

NOS2 VASP FN1 PAF1 CARD11

2.55e-05372175CID009798973
Drugkhellin

ACTA1 ACTA2 ACTC1 HAVCR1 COL7A1 COL11A2 FN1 CORO1A KAT6B

4.03e-051712179CID000003828
DrugAC1L8NVR

ACTA1 ACTA2 ACTC1 DHDDS

4.23e-05212174CID000384633
Drugpotassium bromate

ERCC4 VIT HAVCR1 MYLK3 SPATA22 PLCH2 TNS1

7.55e-051072177ctd:C019536
Drugp-nitrophenylalanine

MME SPPL3 ECE1 ENG

8.68e-05252174CID000013706
Drugtroglitazone; Down 200; 10uM; PC3; HT_HG-U133A

TANC2 KLF12 ZBTB38 ACTA2 USF2 COL7A1 ADAMTS1 TENT5A VPS13D

8.74e-0518921791232_DN
DrugCGS 26303

MME ECE1

9.04e-0522172ctd:C089987
DrugCGS 34043

MME ECE1

9.04e-0522172ctd:C404931
DrugCGS 35066

MME ECE1

9.04e-0522172ctd:C404932
Drugnaphthyl)hydroxy-naftopidil

SYNM PAF1

9.04e-0522172CID000131580
Drugthioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A

NR2F6 ACACB DAG1 FGFR1 HOXB13 ECE1 ATP10D VPS13D TNS1

9.47e-0519121794454_DN
Drug94 PU

HSPG2 REM1 PDCD7 DCHS1

1.02e-04262174CID000023940
Drugindoxacarb

ERAL1 PRMT5 SCN10A USF2 LAMA2

1.02e-04492175CID000107720
DrugGraveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A

ACACB SIGLEC8 ACTA1 DLC1 SCN10A AHSG NPTX2 GYPB CNGB3

1.03e-0419321794276_UP
Drugpyrachlostrobin

HEXB ACTA2 WNK1 CNTN6 NFATC1 AEBP1 GLI2 FGFR1 KIF11 HSPG2 SHROOM3 FN1 ADAMTS1 LAMA5 CPZ DDIAS LRP2 AJUBA TNS1 CDH9

1.05e-0481121720ctd:C513428
DrugFenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A

ACTC1 SNX19 WIPF2 MIIP FN1 MLXIP VPS13D XPNPEP3 CNGB3

1.07e-0419421791422_UP
DrugNadolol [42200-33-9]; Up 200; 13uM; PC3; HT_HG-U133A

ERCC4 SIGLEC8 DLC1 SGSM2 KMT2A MME IFFO1 CELSR3 EFR3B

1.07e-0419421794021_UP
DrugH-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A

ZBTB38 ACACB WNK1 SGSM2 KMT2A USF2 HSPG2 PCLO KDM4A

1.07e-0419421796921_UP
DrugBenfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A

ZBTB38 WNK1 KMT2A MIIP TEDC2 ZNF783 XPNPEP3 TCF25 CEP152

1.07e-0419421794312_DN
DrugHydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A

ACACB ACTA1 FBXO42 FAT4 FRAS1 REM1 FN1 IFFO1 VPS13D

1.07e-0419421793284_UP
DrugAmprolium hydrochloride [137-88-2]; Up 200; 12.6uM; PC3; HG-U133A

KLF12 ACTC1 FGFR1 USF2 MAP7 KHSRP VPS13D GYPB TNS1

1.11e-0419521791898_UP
DrugEtofylline [519-37-9]; Up 200; 17.8uM; HL60; HG-U133A

ACTC1 DGLUCY NFATC1 SGSM2 FBXO42 FGFR1 FN1 TEDC2 CRMP1

1.11e-0419521791409_UP
DrugPhenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A

ACACB AEBP1 FN1 OBSL1 OCA2 ATP10D CRMP1 MYO15A TNS1

1.11e-0419521792868_UP
DrugNefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A

ABCC3 SPEG APC2 FGFR1 COL7A1 FRAS1 DDX51 ECE1 TCHH

1.11e-0419521792317_UP
DrugHomosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A

ABCC3 VPS13C MIIP FAT4 NPTX2 TENM4 KANK3 TCF25 TNS1

1.11e-0419521794355_UP
DrugMerbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A

KLF12 WNK1 SCN10A FGFR1 HSPG2 REM1 OBSL1 LRP2 TNS1

1.15e-0419621794722_UP
DrugAmyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A

ABCC3 SIGLEC8 SPEG NFATC1 KMT2A COL7A1 ECE1 GYPB TNS1

1.15e-0419621794169_UP
DrugCitalopram hydrobromide [59729-32-7]; Up 200; 1uM; MCF7; HT_HG-U133A

ABCC3 ACACB CUL9 SCN10A KMT2A FGFR1 NCOR2 PLCH2 PROP1

1.15e-0419621793903_UP
DrugPentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A

ABCC3 JAK3 NFATC1 COL7A1 FRAS1 NPTX2 IFFO1 LAMA2 ECE1

1.15e-0419621793387_UP
Drugrosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A

ZBTB48 WNK1 PIK3C2B FN1 TEDC2 MLXIP ARHGEF10L XPNPEP3 ENG

1.15e-0419621791174_DN
DrugTetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A

KLF12 NR2F6 ACACB SPEG FGFR1 MAP7 ZNF783 CORO1A VPS13D

1.15e-0419621794587_DN
DrugDomperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A

NR2F6 KMT2A FGFR1 USF2 VASP FN1 HNRNPUL1 KAT6B TNS1

1.15e-0419621791301_DN
DrugColistin sulfate [1264-72-8]; Up 200; 3uM; PC3; HT_HG-U133A

KLF12 NR2F6 WNK1 JAK3 FN1 LAMA2 MAP7 NCOR2 KANK3

1.15e-0419621794212_UP
DrugScoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A

KLF12 SPEG APC2 WNK1 SCN10A MAP7 CELSR3 CNGB3 EFR3B

1.15e-0419621795111_UP
DrugDinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A

ABCC3 DAG1 DLC1 AEBP1 FGFR1 ZNF783 TCHH CELSR3 RAB11FIP5

1.15e-0419621795409_DN
DrugHydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A

NR2F6 ZBTB48 ITPKB PIK3C2B FBXO42 FGFR1 USF2 HSPG2 CEP152

1.15e-0419621792889_DN
DrugF0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A

ACACB PER2 AHSG FAT4 CNTNAP1 DDX51 NCOR2 CEP152 MYO15A

1.15e-0419621796396_DN
DrugIopromide [73334-07-3]; Up 200; 5uM; PC3; HT_HG-U133A

KLF12 NR2F6 APC2 HSPG2 DDX51 MLXIP ECE1 NCOR2 VPS13D

1.20e-0419721794504_UP
DrugCefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A

ZNF202 WNK1 ITPKB USF2 HSPG2 ECE1 ARHGEF10L XPNPEP3 CEP152

1.20e-0419721793319_DN
DrugIocetamic acid [16034-77-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A

SPEG FAT2 NPTX2 ARHGEF28 FN1 IFFO1 ATP10D CRMP1 EFR3B

1.20e-0419721793361_UP
Drugretinoic acid; Down 200; 1uM; MCF7; HG-U133A

NFATC1 FGFR1 NOS2 TEDC2 LAMA2 ECE1 GYPB CNGB3 ENG

1.20e-041972179224_DN
Drugfluphenazine dihydrochloride; Down 200; 10uM; MCF7; HG-U133A

ACACA PIK3C2B FGFR1 USF2 TEDC2 KHNYN CORO1A MTRF1 GYPB

1.20e-041972179490_DN
DrugTrioxsalen [3902-71-4]; Up 200; 17.6uM; HL60; HT_HG-U133A

KLF12 SIGLEC8 DLC1 PXDN FGFR1 NOS2 KHSRP CELSR3 RAB11FIP5

1.20e-0419721792516_UP
Drugrotenone; Up 200; 1uM; MCF7; HT_HG-U133A

ACACB CUL9 ZNF202 AEBP1 FN1 COMP ECE1 KHSRP TNS1

1.20e-0419721795915_UP
DrugClofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A

KLF12 PER2 AEBP1 KLK15 HSPG2 FAT4 REM1 DDX51 ECE1

1.20e-0419721796830_UP
Drugrofecoxib; Up 200; 10uM; MCF7; HG-U133A

NFATC1 KMT2A FGFR1 NOS2 MIIP IFFO1 CRMP1 NCOR2 DCHS1

1.20e-041972179205_UP
DrugEthisterone [434-03-7]; Up 200; 12.8uM; HL60; HT_HG-U133A

ABCC3 SIGLEC8 SCN10A HSPG2 COL7A1 REM1 MAP7 ECE1 CNGB3

1.20e-0419721792366_UP
DrugDoxazosin mesylate [77883-43-3]; Up 200; 7.4uM; PC3; HT_HG-U133A

JAK3 HAVCR1 SCN10A AHSG IFFO1 ZNF783 NCOR2 GYPB XPNPEP3

1.20e-0419721796642_UP
DrugMethylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; HL60; HT_HG-U133A

BCAS3 SIGLEC8 APC2 SYNM LAMA2 POU3F3 ECE1 EFR3B SMAD9

1.20e-0419721793040_UP
DrugBenoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; PC3; HT_HG-U133A

ABCC3 ZBTB48 SPEG DAG1 FAT4 TEDC2 PCLO CNGB3 CEP152

1.20e-0419721793996_DN
DrugMianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

ZBTB48 SPEG NFATC1 SGSM2 WIPF2 CDC42BPB ATP10D XPNPEP3 ACIN1

1.25e-0419821792068_DN
Druggentamicin

SAV1 DAG1 HAVCR1 KIDINS220 HSF4 NOS2 FN1 LRP2 CARD11

1.25e-041982179CID000003467
DrugNovobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A

NR2F6 SPEG DAG1 DLC1 SGSM2 FBXO42 COL7A1 DDX51 MAP7

1.25e-0419821794569_DN
DrugThalidomide [50-35-1]; Up 200; 15.4uM; HL60; HG-U133A

NR2F6 ACACA ACTC1 ZNF202 DLC1 SGSM2 FBXO42 USF2 PAF1

1.25e-0419821791411_UP
DrugNomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A

ACACB ZBTB48 COL7A1 FN1 OBSL1 OCA2 MLXIP TENM4 GYPB

1.25e-0419821796525_UP
Drugnitrendipine; Down 200; 10uM; MCF7; HG-U133A

ACACA ZBTB48 AEBP1 PIK3C2B KMT2A COL7A1 TEDC2 ECE1 EFR3B

1.25e-041982179336_DN
DrugProparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A

KLF12 ZBTB48 SPEG CUL9 ZNF202 ITPKB KIAA0753 USF2 FAM131A

1.25e-0419821796332_DN
DrugBephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A

ABCC3 SPEG ACTA1 SCN10A NPTX2 ARHGEF28 PCLO KHSRP VPS13D

1.25e-0419821795628_UP
DrugClopamide [636-54-4]; Down 200; 11.6uM; PC3; HT_HG-U133A

KLF12 ACACB SPEG USF2 WIPF2 VASP FAT4 ECE1 TNS1

1.25e-0419821796301_DN
DrugIopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A

SPEG CUL9 ZNF202 USF2 TEDC2 LAMA5 MAP7 ARHGEF10L VPS13D

1.29e-0419921795832_DN
DrugAustricine [10180-88-8]; Up 200; 14.2uM; PC3; HT_HG-U133A

KLF12 NR2F6 SPEG ACTA1 IFFO1 NCOR2 CNGB3 CEP152 TNS1

1.29e-0419921794213_UP
DrugAceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A

SAV1 DAG1 DLC1 FBXO42 KHNYN LAMA5 ZNF783 TCHH SOS1

1.29e-0419921797029_UP
DrugAconitine [302-27-2]; Up 200; 6.2uM; HL60; HG-U133A

ACTC1 KIAA0753 USF2 WIPF2 CNTNAP1 OBSL1 KHSRP GYPB TNS1

1.29e-0419921791784_UP
DrugAC1L1B5H

MME KLK15 TCF20

1.33e-04112173CID000001291
DrugGuanadrel sulfate [22195-34-2]; Up 200; 7.6uM; HL60; HT_HG-U133A

ERCC4 SPEG KMT2A TEDC2 LAMA2 KHSRP GYPB CNGB3 ENG

1.34e-0420021792575_UP
Drugprochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A

NR2F6 ERCC4 CUL9 DLC1 PCLO CORO1A VPS13D XPNPEP3 CEP152

1.34e-0420021795212_DN
DrugHydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A

TANC2 ABCC3 ACTC1 WNK1 FGFR1 NPTX2 ARHGEF28 CEP152 TNS1

1.34e-0420021791524_UP
DrugLt 2

WNK1 NOS2 FN1 PAF1 PDCD7

1.49e-04532175CID003042936
Drugazaspiracid

ACTA1 ACTA2 ACTC1 DHDDS

1.81e-04302174CID006451158
DiseaseMalignant neoplasm of breast

NR2F6 APC2 ACTA2 WNK1 MRPS22 CNTN6 ZC3H11A PER2 FGFR1 MME NOS2 HOXB13 KLK15 COL7A1 FN1 ADAMTS1 RCCD1 ZSWIM5 LAMA2 FAM131A OCA2 FCRL5 KAT6B TNS1

1.33e-06107421624C0006142
DiseaseAbnormality of refraction

KLF12 ZBTB38 BCAS3 ZC3H11B ITPKB DLC1 NFATC1 TENT5A PCLO PHRF1 SPPL3 LAMA2 PCDHAC1 CPZ OCA2 CRMP1 PLCH2 CNGB3

2.65e-0667321618HP_0000539
DiseaseMoyamoya disease (implicated_via_orthology)

ACTA1 ACTA2 ACTC1

2.11e-0582163DOID:13099 (implicated_via_orthology)
Diseaseautosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)

ACTA1 ACTA2 ACTC1

2.11e-0582163DOID:0110550 (implicated_via_orthology)
DiseaseBaraitser-Winter syndrome 1 (implicated_via_orthology)

ACTA1 ACTA2 ACTC1

2.11e-0582163DOID:0081112 (implicated_via_orthology)
Diseasethoracic aortic aneurysm (implicated_via_orthology)

ACTA1 ACTA2 ACTC1

2.11e-0582163DOID:14004 (implicated_via_orthology)
DiseaseMammary Carcinoma, Human

NR2F6 APC2 ACTA2 MRPS22 ZC3H11A FGFR1 MME NOS2 HOXB13 COL7A1 FN1 ADAMTS1 RCCD1 ZSWIM5

3.64e-0552521614C4704874
DiseaseMammary Neoplasms, Human

NR2F6 APC2 ACTA2 MRPS22 ZC3H11A FGFR1 MME NOS2 HOXB13 COL7A1 FN1 ADAMTS1 RCCD1 ZSWIM5

3.64e-0552521614C1257931
DiseaseMammary Neoplasms

NR2F6 APC2 ACTA2 MRPS22 ZC3H11A FGFR1 MME NOS2 HOXB13 COL7A1 FN1 ADAMTS1 RCCD1 ZSWIM5

3.79e-0552721614C1458155
Diseaseintestinal atresia (implicated_via_orthology)

ACTA1 ACTA2 ACTC1

4.47e-05102163DOID:10486 (implicated_via_orthology)
Diseasepatent ductus arteriosus (implicated_via_orthology)

ACTA1 ACTA2 ACTC1

4.47e-05102163DOID:13832 (implicated_via_orthology)
DiseaseBreast Carcinoma

NR2F6 APC2 ACTA2 MRPS22 ZC3H11A FGFR1 MME NOS2 HOXB13 COL7A1 FN1 ADAMTS1 RCCD1 ZSWIM5

4.74e-0553821614C0678222
DiseaseHyalinosis, Segmental Glomerular

ACTA2 HAVCR1 NOS2 FN1

4.98e-05282164C0086432
DiseaseVan Maldergem Wetzburger Verloes syndrome

FAT4 DCHS1

5.33e-0522162C1832390
DiseaseVan Maldergem syndrome

FAT4 DCHS1

5.33e-0522162cv:C1832390
DiseasePeriventricular gray matter heterotopia

FAT4 DCHS1

5.33e-0522162C1849173
Diseasesevere combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, Nk cell-positive (implicated_via_orthology)

JAK3 CORO1A

5.33e-0522162DOID:0090014 (implicated_via_orthology)
Diseaseautosomal recessive limb-girdle muscular dystrophy type 2D (is_implicated_in)

DAG1 SGCA

5.33e-0522162DOID:0110278 (is_implicated_in)
DiseaseColorectal Carcinoma

ABCC3 ACACA APC2 WNK1 DLC1 MYLK3 NFATC1 PKHD1 COL7A1 FN1 ARHGEF10L ZNHIT6 DCHS1 LRP2 ACIN1 SMAD9

6.63e-0570221616C0009402
DiseaseFocal glomerulosclerosis

ACTA2 HAVCR1 NOS2 FN1

1.37e-04362164C0017668
Diseaseprostate cancer (is_marker_for)

KMT2A FGFR1 HOXB13 KDM4A ENG SMAD9 SOS1

1.58e-041562167DOID:10283 (is_marker_for)
Diseaseautosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)

VPS13C VPS13D

1.59e-0432162DOID:0111611 (implicated_via_orthology)
DiseaseHeterotopia, Periventricular, Autosomal Recessive

FAT4 DCHS1

1.59e-0432162C1842563
DiseaseDisorder of eye

CDH23 DHDDS FRAS1 COL11A2 OCA2 KIF7 CNGB3 RP1

1.79e-042122168C0015397
DiseaseDisproportionate short stature

FGFR1 HSPG2 COL11A2 COMP OBSL1

2.58e-04772165C0878659
Diseasegastric adenocarcinoma

CHD6 JRK

3.17e-0442162EFO_0000503
DiseaseT-cell non-Hodgkin lymphoma (is_implicated_in)

JAK3 FGFR1

3.17e-0442162DOID:0081312 (is_implicated_in)
Diseasedepressive symptom measurement

ERCC4 DAG1 TENM2 ZBTB37 PKHD1 KMT2A TCF20 PCLO SPPL3 ECE1 CDH9

3.29e-0442621611EFO_0007006
Diseaseosteochondrodysplasia (is_implicated_in)

HSPG2 COL11A2 COMP

3.44e-04192163DOID:2256 (is_implicated_in)
DiseaseKidney Diseases

ACTA2 WNK1 HAVCR1 NOS2 LRP2

4.80e-04882165C0022658
Diseasemuscular disease (implicated_via_orthology)

ACACA ACACB

5.26e-0452162DOID:0080000 (implicated_via_orthology)
Diseasecortical thickness

CUL9 VIT TENM2 DLC1 FBXO42 PKHD1 KMT2A FGFR1 HSPG2 SHROOM3 LAMA2 POU3F3 ECE1 KIAA1614 CRMP1 MBLAC1 CORO1A VPS13D TNS1

5.78e-04111321619EFO_0004840
DiseaseNeurodevelopmental Disorders

TANC2 SYNGAP1 KMT2A DOCK8 CDC42BPB

6.18e-04932165C1535926
DiseaseUreteral obstruction

ACTA2 NOS2 FN1

6.99e-04242163C0041956
Diseaseobsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa

ERCC4 TENM2 SNX19 FGFR1 TCF20 PCLO SPPL3

7.09e-042002167EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Diseaseventral hernia

ZC3H11B TNS1

7.85e-0462162EFO_1001866
DiseaseCongenital muscular dystrophy (disorder)

DAG1 LAMA2

7.85e-0462162C0699743
Diseasediabetic angiopathy (implicated_via_orthology)

NOS2 FN1

7.85e-0462162DOID:11713 (implicated_via_orthology)
DiseasePituitary Hormone Deficiency, Combined, 1

GLI2 PROP1

7.85e-0462162C2751608
DiseaseAcute kidney injury

HEXB HAVCR1 AHSG NOS2 LRP2

8.99e-041012165C2609414
DiseaseKidney Failure, Acute

HEXB HAVCR1 AHSG NOS2 LRP2

8.99e-041012165C0022660
DiseaseAcute Kidney Insufficiency

HEXB HAVCR1 AHSG NOS2 LRP2

8.99e-041012165C1565662
Diseaseprostate carcinoma

TANC2 ZBTB38 CNTN6 CILP2 PIK3C2B FMN1 PKHD1 HOXB13 KLK15 SHROOM3 RCCD1 CRMP1 CEP152 HTR3B SMAD9 SOS1

9.30e-0489121616EFO_0001663
Diseaseunipolar depression, bipolar disorder

ERCC4 TENM2 FAT4 PCLO SPPL3 TENM4

1.05e-031562166EFO_0003761, MONDO_0004985
Diseasearteriovenous malformations of the brain (implicated_via_orthology)

ENG SMAD9

1.09e-0372162DOID:0060688 (implicated_via_orthology)
DiseaseOROFACIODIGITAL SYNDROME VI

KIAA0753 KIF7

1.09e-0372162C2745997
DiseaseCleft palate, cleft lip

TANC2 TENM2 DLC1 PKHD1 FGFR1 SHROOM3 CRMP1 TENM4

1.10e-032792168EFO_0003959, HP_0000175
Diseaseosteoarthritis (is_implicated_in)

FGFR1 TENT5A NCOR2

1.11e-03282163DOID:8398 (is_implicated_in)
Diseasehair morphology

SLC23A1 FRAS1 TCHH

1.23e-03292163EFO_0005038
DiseaseFamilial pulmonary arterial hypertension

ENG SMAD9

1.45e-0382162C1701939
Diseasecerebellar ataxia (implicated_via_orthology)

VPS13C GEMIN5

1.45e-0382162DOID:0050753 (implicated_via_orthology)
Diseasehypertension (biomarker_via_orthology)

ACTC1 HAVCR1 NOS2 HSPG2 FN1 ECE1 ENG

1.48e-032272167DOID:10763 (biomarker_via_orthology)
DiseaseIntellectual Disability

TANC2 APC2 SYNGAP1 TCF20 DOCK8 PTPN23 POU3F3 KIF7 LRP2 ACIN1

1.79e-0344721610C3714756
Diseasesevere acute respiratory syndrome, COVID-19

ABCC3 KLF12 TENM2 CNTN6 PXDN GLI2 SLC23A1 ARHGEF28 CRMP1 TNR

1.79e-0344721610EFO_0000694, MONDO_0100096
DiseaseFEV/FEC ratio

BCAS3 VPS13C SPEG CDH23 ZC3H11B DLC1 NFATC1 FGFR1 WIPF2 HSPG2 FRAS1 ARHGEF28 ADAMTS1 MBIP CORO1A GYPB MYO15A AJUBA TNS1

1.81e-03122821619EFO_0004713
Diseaseprimary bacterial infectious disease (implicated_via_orthology)

GLI2 DUOX2

1.86e-0392162DOID:0050338 (implicated_via_orthology)
Diseasepack-years measurement, systolic blood pressure

GYPB DCHS1 LRP2

1.96e-03342163EFO_0006335, EFO_0006526
DiseaseSpinocerebellar Ataxia Type 2

STUB1 MME ATXN1L

1.96e-03342163C0752121
DiseaseSpinocerebellar Ataxia Type 1

STUB1 MME ATXN1L

1.96e-03342163C0752120
DiseaseSpinocerebellar Ataxia Type 5

STUB1 MME ATXN1L

1.96e-03342163C0752123
DiseaseSpinocerebellar Ataxia Type 7

STUB1 MME ATXN1L

1.96e-03342163C0752125
DiseaseSpinocerebellar Ataxia Type 6 (disorder)

STUB1 MME ATXN1L

1.96e-03342163C0752124
DiseaseAtaxia, Spinocerebellar

STUB1 MME ATXN1L

1.96e-03342163C0087012
Diseaseserum alanine aminotransferase measurement

ZC3H11B DGLUCY CILP2 PAQR9 SHROOM3 PCLO LAMA5 CDCP2 MLXIP ATP10D NSUN3 TENM4 ZNF517 APOL5 RP1

1.96e-0386921615EFO_0004735
Diseasehair colour measurement

ZBTB38 ZNF831 PXDN NFATC1 PKHD1 FRAS1 SHROOM3 ADAMTS1 OCA2 TENM4 TCF25 SMAD9

2.04e-0361521612EFO_0007822
DiseaseSpinocerebellar Ataxia Type 4

STUB1 MME ATXN1L

2.13e-03352163C0752122
Diseaseurate measurement, bone density

KLF12 ERCC4 TENM2 SNX19 ITPKB KIDINS220 GLI2 FBXO42 SLC23A1 FRAS1 LAMA5 KAT6B

2.15e-0361921612EFO_0003923, EFO_0004531
Diseasehair color

ZBTB38 ZNF831 PKHD1 WIPF2 FRAS1 TCF20 OCA2 TCF25

2.17e-033112168EFO_0003924
Diseaseurea measurement

BCAS3 SHROOM3

2.31e-03102162EFO_0011005
DiseaseHoloprosencephaly sequence

GLI2 FGFR1

2.31e-03102162cv:C0079541
Diseasewhite matter microstructure measurement

DAG1 TENM2 NFATC1 ECE1 KIAA1614 CORO1A LRP2 CARD11 SOS1

2.44e-033902169EFO_0005674
Diseasetea consumption measurement

CUL9 DHDDS PKHD1 LAMA2 SRRM3

2.65e-031292165EFO_0010091
DiseaseSensory hearing loss

COL11A2 LRP2

2.81e-03112162C1691779
DiseaseUmbilical hernia

ZC3H11B FMN1

2.81e-03112162HP_0001537
DiseaseNonsyndromic Deafness

CDH23 COL11A2 TMEM132E MYO15A

2.99e-03812164C3711374
Diseasevaline measurement

ACACB NFATC1 MLXIP

3.13e-03402163EFO_0009792
Diseasemacrophage inflammatory protein 1b measurement

ACACA DAG1 QARS1 COL7A1 TMEM132E

3.33e-031362165EFO_0008219
DiseaseEssential Hypertension

NOS2 ECE1

3.35e-03122162C0085580
Diseaserenal fibrosis (biomarker_via_orthology)

ECE1 ENG

3.35e-03122162DOID:0050855 (biomarker_via_orthology)
DiseaseCombined immunodeficiency

DOCK8 CORO1A CARD11

3.36e-03412163C0494261
Diseasecolitis (biomarker_via_orthology)

UCN2 HAVCR1 NOS2

3.60e-03422163DOID:0060180 (biomarker_via_orthology)
Diseaseapolipoprotein B measurement

KLF12 ACACB HAVCR1 CILP2 VASP PAQR9 FN1 ATXN1L XPNPEP3 RP1 SRRM3 CEACAM20

3.74e-0366321612EFO_0004615
Diseasebeta-amyloid 1-42 measurement

DLC1 DMRTB1 CARD11 CDH9

3.87e-03872164EFO_0004670
Diseaseascorbic acid 2-sulfate measurement

CORO1A ZG16

3.95e-03132162EFO_0800169
DiseaseDEAFNESS, AUTOSOMAL RECESSIVE (disorder)

CDH23 TMEM132E

3.95e-03132162C1846647
Diseaseoptic disc size measurement

TANC2 KLF12 BCAS3 DLC1 JRK LRP2

4.12e-032052166EFO_0004832
Diseasecarpal tunnel syndrome

ZBTB38 SNAP47 AEBP1 COL11A2

4.20e-03892164EFO_0004143
DiseaseHbA1c measurement

ZBTB38 ACACB DAG1 ZC3H11B HAVCR1 AEBP1 ERAL1 KIF11 PAQR9 GYPB MYO15A SOS1

4.31e-0367521612EFO_0004541
DiseaseGastric Adenocarcinoma

ERN1 SPEG JAK3

4.38e-03452163C0278701
Diseaseamino acid measurement

TANC2 ACACB PXDN FMN1 GLI2 FAT4 ARHGEF28 SPPL3 MLXIP TENM4 LRP2 ENG

4.46e-0367821612EFO_0005134
Diseasevital capacity

ZBTB38 DHDDS TENM2 PIK3C2B HSPG2 SHROOM3 TCF20 FN1 ADAMTS1 TENT5A PCLO LAMA2 PCDHAC1 NCOR2 GYPB EFR3B LRP2 TNS1

4.49e-03123621618EFO_0004312
Diseaseascorbic acid 3-sulfate measurement

SLC23A1 CORO1A

4.58e-03142162EFO_0800173
Disease2-oxo-hept-3-ene-1,7-dioate hydratase activity

ENG SMAD9

4.58e-03142162C1150929
DiseaseT wave morphology measurement

KLF12 SCN10A

4.58e-03142162EFO_0008398
DiseaseAutosomal recessive limb-girdle muscular dystrophy

DAG1 SGCA

4.58e-03142162cv:C2931907
DiseaseLeft ventricular noncompaction

ACTC1 MIB2

4.58e-03142162C1960469
Diseasesevere combined immunodeficiency (is_implicated_in)

JAK3 TAPBP

4.58e-03142162DOID:627 (is_implicated_in)
Diseasecognitive function measurement, self reported educational attainment

TANC2 PKHD1 QARS1 NPAS1 TCF20 BTAF1 RAB11FIP5 CDH9

4.83e-033552168EFO_0004784, EFO_0008354
Diseasecortical surface area measurement

HEXB TANC2 CUL9 TENM2 FBXO42 PKHD1 FGFR1 QARS1 SHROOM3 SGCA KHNYN LAMA2 POU3F3 KIAA1614 TJP1 GYPB AJUBA TNS1 SOS1

4.88e-03134521619EFO_0010736
Diseasecryptic phenotype measurement

BCAS3 ZNF831 GYPB

4.95e-03472163EFO_0021487

Protein segments in the cluster

PeptideGeneStartEntry
ERPISREAGPVVHQS

nan

21

A4D1N5
EKHVTQRLQPERGSP

ACIN1

716

Q9UKV3
TPGLGHRVPESVELT

C2orf16

351

Q68DN1
HRGQLEISSLVPLGP

ARHGEF10L

581

Q9HCE6
RPSTPGRAHLVSVIV

CCR10

151

P46092
VHGRPQGTLEIPSES

CEP152

1591

O94986
RPVTDGQPHSINITR

CNTNAP1

1136

P78357
RISHLTNRVPPTLNG

ELL2

336

O00472
SPGGIQPHVSRTLFL

LRG1

11

P02750
VQDPVEVPSGGRRAH

CCDC116

111

Q8IYX3
AGSLPPTRQGLLHVV

ANKLE1

241

Q8NAG6
AVFPSIVGRPRHQGV

ACTA1

31

P68133
PLERRGAQPGRHSVT

AJUBA

251

Q96IF1
RRLNATTTLGPHTVP

AEBP1

1036

Q8IUX7
TRPPTLVSLGHELQV

CDCP2

221

Q5VXM1
QVPRSVGSTPLIGHF

HTR3B

291

O95264
VFGTPRTPQIHGRSR

CEACAM20

51

Q6UY09
QSVRTGLPSVRPLLH

COMP

76

P49747
SPARELHLPIRDGNT

FAT4

4716

Q6V0I7
AVFPSIVGRPRHQGV

ACTA2

31

P62736
PRGHVIAARITSENP

ACACA

501

Q13085
RPHEGTRPVRAVFVS

CORO1A

216

P31146
HSNSRRSPLVPGIIT

BCAS3

306

Q9H6U6
FVRPPNGTILHIREE

CDH23

2611

Q9H251
TVPEHSPRGTLVGNV

CDH23

2736

Q9H251
LRVLPGHSAGPRTVT

ENG

221

P17813
SQTPKLSGRHRIVVP

ATP10D

41

Q9P241
PSHLVPAGRSVRVFI

NWD2

31

Q9ULI1
VLRRSEEHSPPRGIN

RBM12B

246

Q8IXT5
GRQVHSPSPLRAGVD

RCCD1

26

A6NED2
LVASGPSRPGREEHI

OCA2

236

Q04671
PSRPGREEHIVVELT

OCA2

241

Q04671
VQRGRIPHSLPGAVA

NR2F6

126

P10588
PRVQVSPERTQVHAG

HSPG2

1956

P98160
EEPQGPVRHRSSISG

RAB11FIP5

346

Q9BXF6
VVPELERAPGHGTTR

ADAMTS1

61

Q9UHI8
IRRPPSGLEHQQTGL

FMN1

281

Q68DA7
APRVGPAGEHRLVTV

JAK3

306

P52333
LGLVPRSSPQHGVVS

PTPN23

831

Q9H3S7
LSARPSTVVPRGGHV

KIR3DL2

31

P43630
VPRRHLGPSEKVQVT

ABCC3

921

O15438
HSEVLEQLGLRTPTP

NPAS1

191

Q99742
LHSPESRPVTGERGQ

KAT6B

1046

Q8WYB5
PPLARGHVIAARITS

ACACB

641

O00763
LPTGRRETVGQVHPL

ARHGEF28

741

Q8N1W1
RETVGQVHPLSRSVP

ARHGEF28

746

Q8N1W1
QVHPLSRSVPGTTLE

ARHGEF28

751

Q8N1W1
GILERVVDGPTPHQT

NOS2

786

P35228
HRRLVLPATQPSDGG

OBSL1

861

O75147
RVSHLRPEPSETGVS

FAM47C

506

Q5HY64
VGPPETSLHTVVQGR

FBXO42

671

Q6P3S6
HDVRSLIGSPGRTFP

NCOR2

1471

Q9Y618
RGSPPQLTHVTVRVA

DCHS1

1726

Q96JQ0
TPGRIPSERHQIGNL

NSUN3

96

Q9H649
VVVPRSLVDLSTPGH

OR10AC1

76

Q8NH08
RGIPHSLSGLQDPII

KIDINS220

1626

Q9ULH0
IVQPPRHGTIERTSN

FRAS1

2351

Q86XX4
VTPPEGSSRRRIIHG

MAP7

276

Q14244
IHGRVGRFPSELVQP

MYO15A

2936

Q9UKN7
GRVTIQEDPPGHLSV

FNDC7

291

Q5VTL7
GRVITALVERTPHVP

KIF11

296

P52732
ILRPTSGLVAPGAHQ

CFAP65

821

Q6ZU64
QTPRVEVAAPAHRGT

ATXN1L

316

P0C7T5
PLRASHDIVPTITQG

KIAA1614

386

Q5VZ46
RRQIHATPTPVTAIG

DAG1

311

Q14118
FITRTPGERSHPQGL

DUOX2

966

Q9NRD8
EPPSRVNSRTGVGTH

PER2

636

O15055
RIESQHGIERPRTAP

PCLO

3846

Q9Y6V0
HGIERPRTAPQTEFS

PCLO

3851

Q9Y6V0
VPQRTHAGPSLGEVR

PDCD7

161

Q8N8D1
SGQPPLSASVRLHIE

FAT2

1321

Q9NYQ8
RPVLTLRAPGTHAAV

FCRL5

751

Q96RD9
DGPEQLRTTSRVIPH

KLK15

81

Q9H2R5
VPSVREHFRTIGLPE

JRK

276

O75564
QIVVGVRDSGSPPLH

PCDHGC5

531

Q9Y5F6
QARATHSGGETPPRI

MYLK3

321

Q32MK0
PRPSLHQAVDTGRTG

EFR3B

406

Q9Y2G0
QRTTGALHTPPIALR

DDIAS

466

Q8IXT1
VGPHVARERVIPFSS

ERAL1

21

O75616
VIHIDQPRLGLPSRD

MME

216

P08473
RLVFRVHVPQPSGRT

NFATC1

561

O95644
PRSARPVLDTHGVII

COL11A2

176

P13942
ISALGDPQRRGSHIP

KIF7

286

Q2M1P5
SHQPVARPVSVGLSR

PHRF1

471

Q9P1Y6
PVRPTHSSVRQVEDG

KDM4A

436

O75164
EPSPTGRHRGVRAVQ

GLI2

1376

P10070
NPQVIIRGGTPTHAR

LAMA2

1271

P24043
TENLGHPRGIAVDPT

LRP2

506

P98164
LSTDRQVVPHERQPG

LAMA5

1656

O15230
VLRNTEILPPGSHTG

CDC42BPB

376

Q9Y5S2
PERIQPGLFDIIGHS

PAQR9

296

Q6ZVX9
HPGRSSRAPFQIIRI

PTER

201

Q96BW5
RISAAPVGSRPHTVA

PIK3C2B

306

O00750
HARRLGPGLEPTLVQ

IFFO1

201

Q0D2I5
PVEIVPRSARTGHLV

PCDHAC1

566

Q9H158
GREEPPRRQQIIHSG

MLXIP

66

Q9HAP2
LPATGVPVTRRQFDH

MLXIP

801

Q9HAP2
RPNSHRTLPERSGVV

PAF1

16

Q8N7H5
VTDPHSPARFRVLGT

EEF1AKMT4-ECE2

841

P0DPD8
GETGQLVHRFTVPAP

GYPB

46

P06028
SLPHISVARRPDGAV

APC2

2101

O95996
AETRGARSDHIPIPQ

CPZ

336

Q66K79
TTPFTLEGRPRGELH

DOCK8

1896

Q8NF50
RLDGSIPPGQRHSIV

BTAF1

1676

O14981
HEGVAVVPRGSTLPL

ERN1

301

O75460
NHTLAEPILRDTGPR

CHD6

2426

Q8TD26
PRALQPVLGGRSHVE

DMRTB1

131

Q96MA1
PVLGGRSHVEPSERA

DMRTB1

136

Q96MA1
TPGRLVDHIDQTPGF

DDX51

346

Q8N8A6
DVVERSPHRPILQAG

FGFR1

246

P11362
GEVSHPRKTRTVVQP

AHSG

331

P02765
LPGEHGQRLPISRNT

FN1

946

P02751
LQRVGHFDPVTRSPL

STUB1

261

Q9UNE7
HSVAEGVRLSPEPGR

ZNHIT6

16

Q9NWK9
GHRFSRPVRQGSVEP

FAM131A

226

Q6UXB0
QDITLSIRPETHSPG

PRMT5

561

O14744
GLLSRPIFTQEPHDV

CNTN6

21

Q9UQ52
GLSPHRARGPIISDI

HSF4

251

Q9ULV5
LVLPQTRGPASSHRE

MBLAC1

46

A4D2B0
EAHLRLQTGGPVPRD

MBIP

256

Q9NS73
LELAQTHERAPSPGR

KANK3

141

Q6NY19
VPGQPDLRHIVIDGS

KHNYN

431

O15037
AVQEVHPSPVSRVRG

KLF12

266

Q9Y4X4
HVTLTNPRLLGTPDI

KMT2A

3361

Q03164
VLRLHEPGPQRSGEA

CUL9

1831

Q8IWT3
ARTDPLGPVRTVHVT

COL7A1

681

Q02388
GLITDPHSPSRFRVI

ECE1

726

P42892
GLPRRDPAGHSQTTV

DGLUCY

136

Q7Z3D6
EPGPRSATVRVHITV

CELSR3

521

Q9NYQ7
RGIRVLPEFDTPGHT

HEXB

281

P07686
VSVVQTLGAPGEPRH

HOXB13

146

Q92826
DVTIGPRTVIHPKAR

DCTN6

26

O00399
RSPHPDILIRTSGEV

DHDDS

196

Q86SQ9
PEAGLHTAPLQERRI

PIWIL3

81

Q7Z3Z3
NSPESVPLGTHLGRI

CDH9

276

Q9ULB4
AQSLVHPGLVRGDTP

POU3F3

251

P20264
ERPFRPSVTSVGHVR

CARD11

646

Q9BXL7
HRIVAPPGGRSNITS

CRMP1

556

Q14194
ERGQDIRIPTPVIHT

CKMT1A

401

P12532
VPENLPRHGTVGLIT

PCDH11Y

611

Q9BZA8
PRHGTVGLITVTDPD

PCDH11Y

616

Q9BZA8
TRPSQRRVTFHLPEG

PCDH11Y

1041

Q9BZA8
RGHQPGRLSTVPSTQ

REM1

26

O75628
QHLPLSERIRGTVGP

HNRNPUL1

401

Q9BUJ2
VVELGRHGSPSTPDR

MIB2

36

Q96AX9
RHGSPSTPDRTVVVQ

MIB2

41

Q96AX9
LPFGVRNISTPRGRH

RP1

76

P56715
TGTPLVAGSPIRHEN

ISL2

271

Q96A47
DVPVPRHSVGVVIGR

KHSRP

326

Q92945
PHRERFIVVREPSGT

MRPS22

166

P82650
GVRVTPQEGHLPALR

RTL1

1201

A6NKG5
HLEITGGQVRTRFPP

QARS1

256

P47897
PSLIRRFQGVSLPVH

MRPL39

291

Q9NYK5
DRPGGHIVAETPRLT

SRRM3

106

A6NNA2
RTLHREPPAGDQEGT

SNAP47

381

Q5SQN1
DTGQIPHSVSRPLRS

SPATA22

76

Q8NHS9
GQDTDTLVGLPRPIH

STRIP2

446

Q9ULQ0
VGARAESPTQHPLLR

TMEM132E

256

Q6IEE7
VRHVTLGPGQSPLSR

SYNM

1171

O15061
GLRQTTVPAKGHPER

TEDC2

141

Q7L2K0
VAARVTSTGPHRPQD

ITPKB

306

P27987
ETHPTTLQGAIRREP

HAVCR1

236

Q96D42
HEERLEGLRTPQLTP

SPATA31A7

1121

Q8IWB4
GPGTLAQPAHVRVSI

MIIP

271

Q5JXC2
PSADELVQRHRIRGP

SGSM2

196

O43147
RSSNPGLLELPRVHV

SIGLEC8

306

Q9NYZ4
VLAGPVHVRSRSSPA

SHROOM3

1231

Q8TF72
LVDILRHQAGPGTRP

SHISA7

226

A6NL88
QLGSPDVSHLIRRPI

TANC2

1741

Q9HCD6
EPHVLAGTITPTIGR

TENM2

1791

Q9NT68
PLPAGLHRISVSING

PKHD1

1166

P08F94
VHLAPRTQLDGRSDP

KIAA0753

11

Q2KHM9
LPRDPGHVVEQLSRS

NPTX2

116

P47972
FIQVTLPHGPRSASV

SOS1

1121

Q07889
GIHRVQRIPEVGLSS

MTRF1

256

O75570
GTPTNLRRHVPDLES

DLC1

381

Q96QB1
HTGERLPPRVDSAQV

SGCA

366

Q16586
RHVVLSIPNGDFRPV

SMAD9

251

O15198
AVFPSIVGRPRHQGV

ACTC1

31

P68032
VEHQPRLGPGVALRT

APOL5

386

Q9BWW9
PSAVGERVHLNPTRG

CILP2

106

Q8IUL8
EPHSVRRTVLPRGTS

CNGB3

766

Q9NQW8
RPHSALLAVRVEPGG

CNNM3

111

Q8NE01
AHRVSGALIRPLPSQ

TMX3

126

Q96JJ7
SFIRHGPTIPRRTDI

SAV1

36

Q9H4B6
HEERLEGLRTPQLTP

SPATA31A3

1121

Q5VYP0
TLGLVPRDQEPRGSH

ZBTB48

156

P10074
PFSGLGEVIHRESVP

ZSWIM5

721

Q9P217
PSGSVVPLTERHRAR

ZBTB37

311

Q5TC79
HEERLEGLRTPQLTP

SPATA31A1

1121

Q5TZJ5
HVSVPQSGLRREEPD

SPEG

271

Q15772
LLRRTVSVPVEGRPH

SYNGAP1

81

Q96PV0
PPVHAINRGIFTEGI

SLC23A1

351

Q9UHI7
HEERLEGLRTPQLTP

SPATA31A5

1121

Q5VU36
ERLHARGPTSEPLVI

PAPLN

266

O95428
HFRSPGRDISLPEGV

SCN10A

506

Q9Y5Y9
TDGRSQPRTLGHLPV

PLCH2

1076

O75038
HLGPNVGRDVPRLSL

SPPL3

236

Q8TCT6
VLTHTPAPRVRLGQD

TAPBP

161

O15533
PEVHNGLRVTSVRKP

ZC3H11A

186

O75152
HPTGVTRRRIQPEED

TNS1

996

Q9HBL0
ERGETPPRSQHVSLS

FAM170A

91

A1A519
TPPFRVIGELVGHTE

GEMIN5

51

Q8TEQ6
TRPRKIPSVGRQGEH

PXDN

1351

Q92626
RDGVHVLLQGVPSDP

SNX15

296

Q9NRS6
YHEVLVPRGIGPTTR

TNR

636

Q92752
TSIPRPQSVGHRSQE

VIT

211

Q6UXI7
LVGRDSTHIIPGENP

TENM4

901

Q6N022
HVDGRVPFRPSSAVL

SLC35A4

41

Q96G79
VSSLRPPRLIHEDGI

VPS13C

3591

Q709C8
VVPVSNPAHGDGLTR

USF3

1386

Q68DE3
SPLRQIVRDPGAHSL

TCF20

871

Q9UGU0
LQTGTQRTIAPRTHP

USF2

206

Q15853
RVGSNLLPERHPATG

PROP1

16

O75360
QGLVPKPHLETRTGR

SNX19

221

Q92543
HSASPRVLQEDLGRP

ZNF517

156

Q6ZMY9
PEVHNGLRVTSVRKP

ZC3H11B

186

A0A1B0GTU1
VPLHPNTVLRFISGR

ZG16

131

O60844
GVLPNSTHEDGILRP

TJP1

406

Q07157
RPDQGITLGSPQRHD

ZNF786

131

Q8N393
HLLRPGEVTPGLSQV

XPNPEP3

56

Q9NQH7
STIRVVGHVPGEFPV

TMEM130

91

Q8N3G9
RHPGSRIVLSLDVPI

UCN2

66

Q96RP3
PSLIHRRGIDIEPVT

ERCC4

696

Q92889
KRHEEPAITNGPRIT

ZBTB38

151

Q8NAP3
PPLRNGHRDSITTVR

WIPF2

376

Q8TF74
VHSAGRRFIVSPVPE

WNK1

1251

Q9H4A3
TDVPSGHPRALVRQA

ZNF831

551

Q5JPB2
TIPIHGRGNFPTLEL

TENT5A

81

Q96IP4
RLLEPGTHQFASVPV

TCHH

1911

Q07283
VNLRETTPVHPLLGR

ZNF202

381

O95125
VRPERLSPISHGNTI

TCF25

596

Q9BQ70
HTGRNPISVTDVGRP

ZNF805

561

Q5CZA5
PEPGNVTIRGVHILT

nan

56

Q6ZRX8
VTIRGVHILTPEPGN

nan

61

Q6ZRX8
VHILTPEPGNVTIRG

nan

66

Q6ZRX8
HVEEGRQEAPGRSPT

ZNF783

371

Q6ZMS7
PGPSEHIERRVSNAG

VASP

146

P50552
PVVFTQHGVAEPRLR

VPS13D

3526

Q5THJ4